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ABSTRACT 
Sepsis is estimated to annually cause 30 million cases and 6 million deaths worldwide. Since 
2016, sepsis is defined as “life-threatening organ dysfunction caused by a dysregulated host 
response to infection”. Previously, and when this study was conducted, the term “severe sepsis” 
was used to denote organ dysfunction caused by acute infection. 
The aims of Study I were to explore the characteristics, epidemiology and outcome of 
community onset severe sepsis in the adult population in Skaraborg, western Sweden. During a 
9-month period, Sept. 2011 – June 2012, 2,462 consecutive episodes in 2,196 patients admitted 
to Skaraborg Hospital and treated with intravenous antibiotics, were evaluated per protocol. 
Studies II, III and IV were done on parts of this study population. 
The incidence of severe sepsis was estimated to 276/100,000 and of sepsis according to the new 
2016 criteria to 856/100,000 (Study I). Risk factors for acquiring severe sepsis were age >85 
years, cardiovascular disease, and diabetes mellitus. In 429 patients with severe sepsis, the 28-
day case fatality rate was 25%, versus 4% in 1,767 with non-severe sepsis or no sepsis. Risk 
factors for 28-day case fatality were age >85 years, renal-, respiratory-, and cerebral dysfunction. 
During a six week period, blood samples from 383 consecutive episodes of suspected sepsis in 
the emergency department were analyzed by multiplex PCR for rapid detection of pathogenic 
bacteria (Study II). We found that the multiplex PCR added some diagnostic value by detecting 
clinically relevant bacteria not detected by blood culture. 
In Study III, 432 nasopharyngeal samples collected during winter 2012 were examined for 
respiratory viruses using multiplex PCR. We noted that viral infections or co-infections with 
bacteria were underestimated in patients with suspected sepsis, especially Influenza A virus, 
human metapneumovirus and respiratory syncytial virus. 
In study IV, we evaluated lactate, C-reactive protein, procalcitonin (PCT) and the neutrophil to 
lymphocyte count ratio (NLCR) in 1,572 episodes of suspected sepsis. In bacterial sepsis of any 
severity, either the NLCR or PCT alone exhibited equivalent performance. In the most critically 
ill patients, combinations of 3 or 4 biomarkers could improve the diagnosis of bacterial sepsis. 
Study V, performed in a neighboring hospital in Borås, examined six defined symptoms of 
sepsis; fever, dyspnea, acute change of mental status, severe pain, vomiting/diarrhea and muscle 
weakness. Occurrence of >3 of these symptoms significantly predicted the presence of severe 
sepsis or septic shock, especially acute change of mental status and dyspnea. 
In conclusion: The Swedish 2011 criteria for severe sepsis appropriately separated those with a 
high case fatality rate from those with a low. High age was the most significant independent risk 
factor for both incidence and case fatality. Respiratory viral infections were common and 
underdiagnosed in patients with suspected sepsis. Multiplex-PCR added diagnostic value to 
blood culture. Biomarkers were limited in their ability to detect sepsis but improved when 
combined. Symptoms of sepsis can be defined and can be used for rapidly diagnosing sepsis. 
Keywords: bacteremia, biomarker, epidemiology, multiplex-PCR outcome, sepsis, severe 
sepsis, symptoms. 
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SAMMANFATTNING PÅ SVENSKA 
Sepsis har uppskattats orsaka 30 miljoner sjukdomsfall och 6 miljoner dödsfall årligen i världen. 
För att minska sjuklighet och dödlighet är det av största vikt att identifiera sepsis så snabbt som 
möjligt och att tidigt ge effektiv antibiotikabehandling. Sedan 2016 definieras sepsis som 
”livshotande organsvikt orsakad av ett felreglerat immunologiskt svar på en infektion” (Sepsis-
3). Tidigare kallades infektion med organsvikt för ”svår sepsis”, vilket var gällande när denna 
studie genomfördes.  
Sepsis förekommer inom alla specialiteter i sjukvården men det finns ingen bra uppskattning av 
hur vanligt det är i en viss befolkning. Syftet med denna studie var att undersöka förekomsten 
av sepsis/svår sepsis bland vuxna >18 år i Skaraborg, riskfaktorer för att insjukna och avlida, 
samt att undersöka metoder för att snabbt kunna identifiera sepsis. Studieperioden var 9 månader 
mellan september 2011 - juni 2012. 
I den första studien undersöktes alla vuxna patienter som lades in på sjukhuset i Skövde eller 
Lidköping avseende förekomst eller utveckling av svår sepsis under de första 48 timmarna. Som 
definition och kriterier användes de svenska från 2011. Då det 2016 kommit en ny internationell 
definition och nya kriterier (Sepsis-3), utvärderades även dessa. Enligt de svenska kriterierna 
från 2011 fann vi att 276/100 000 invånare årligen insjuknade i svår sepsis. Dödligheten inom 
28-dagar var 25 %. Riskfaktorer för insjuknande var hög ålder och för 28-dagars död hög ålder, 
nedsatt njur-, lung- respektive hjärnfunktion. Tillämpning av 2016 års kriterier visade att 
856/100 000 vuxna årligen insjuknade i sepsis och att dödligheten inom 28-dagar var 12 %. 
I den andra studien jämfördes under en 6-veckorsperiod utfallet av 383 blododlingar med PCR, 
en metod för att snabbt kunna påvisa bakteriers arvsmassa, DNA, i blod. Resultatet visade att 
metoderna kompletterar, men inte ersätter, varandra. 
I den tredje studien utvärderades virusfynd i näsprov hos patienter med misstänkt sepsis. Vi fann 
att virusinfektioner, främst Influensa A, var vanligare förekommande bland patienter med 
misstänkt sepsis än vad behandlande läkare trodde. Dubbelinfektioner med både virus och 
bakterier var inte heller ovanliga, framför allt hos personer med lunginflammation. 
I den fjärde studien utvärderades förmågan hos ofta använda markörer såsom C-reaktivt protein 
(CRP), procalcitonin, neutrofil/lymfocytkvot (NL-kvot) samt laktat att identifiera svåra 
infektioner. Resultaten visade att inget enskilt prov är riktigt bra, men att kombinationen av de 
3 markörerna, laktat, CRP och NL-kvot, resulterade i ökat förmåga att kunna upptäcka patienter 
med svår sepsis och som därför var i behov av snabbt insatt effektiv antibiotikabehandling. 
I den femte studien utförd i Borås, utvärderades förmågan hos sex specifika symtom (feber, 
andnöd, förvirring, smärta, muskelsvaghet och kräkning/diarré) avseende att tidigt kunna 
identifiera patienter med svår sepsis. Förekomst av mer än tre av dessa symtom var starkt 
kopplade till svår sepsis, särskilt andnöd och förvirring. 
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DEFINITIONS IN SHORT 
Sepsis-1 Sepsis-1 is often used to denote the sepsis 
definition and criteria according to the 1991 
American consensus conference on sepsis [1].  
Sepsis was defined as the systemic inflammatory 
response syndrome (SIRS) to a confirmed 
infectious process. Criteria for SIRS were 
presence of 2/4 of: heart rate >90/min, 
respiratory rate >20/min, temperature >38 or 
<36oC or leukocyte count >12 or <4 x 109/ml.  
Severe sepsis was defined as sepsis + organ 
dysfunction, but criteria for organ dysfunction 
were not specified. Thus, different criteria for 
organ dysfunction have been used in clinical 
studies. 
Sepsis-2 Is often used for the definition according to the 
second sepsis consensus conference in 2001 [2]. 
The basic definition of sepsis was retained, but 
the list of sepsis criteria was expanded. 
Criteria for early organ dysfunction were offered. 
These were not meant to be criteria for severe 
sepsis, but have often been used as such in 
clinical studies. 
The 2011 Swedish sepsis 
definition 
The Swedish definition of sepsis was the same as 
in Sepsis-1 and -2. 
Severe sepsis, however, was defined as sepsis or 
verified infection + organ dysfunction. More 
strict criteria for organ dysfunction than Sepsis-2 
were presented [3]. Table 1, p. 3. 
Sepsis-3 Sepsis-3 represents a new definition of sepsis 
launched in 2016 by a third international 
consensus sepsis conference [4]. This new 
definition of sepsis now includes organ 
dysfunction. Sepsis is now defined as “life 
xiii 
threatening organ dysfunction caused by a 
dysregulated immune response to an infection 
[4].  
Thus, the term “severe sepsis” is no longer 
needed. 
Criteria for sepsis-3 is an increase of 2 points or 
more from baseline in the SOFA-score [5]. Table 
2, p. 4. 
Septic shock Septic shock was defined in Sepsis-1 and -2 as 
sepsis-induced hypotension despite adequate 
fluid resuscitation along with the presence of 
perfusion abnormalities [1].  
According to Sepsis-3, septic shock is defined as 
“a subset of sepsis in which underlying 
circulatory, cellular, and metabolic abnormalities 
are associated with a greater risk of mortality 
than sepsis alone. Adult patients with septic 
shock can be identified using the clinical criteria 
of hypotension requiring vasopressor therapy to 
maintain mean blood pressure 65 mm Hg or 
greater and having a serum lactate level greater 
than 2 mmol/L after adequate fluid 
resuscitation”[6]. 
Biomarker A biomarker, or biological marker, generally 
refers to a measurable indicator of some 
biological state or condition, for example a 
certain disease [7]. In clinical medicine, and in 
this text, the term “biomarker” refers to 
laboratory biomarkers. 
Case Fatality Rate (CFR) The percentage of patients having a disease that 
die from that disease. 
Mortality rate The percentage of persons in a population that 
die from a certain disease. 
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1 INTRODUCTION 
1.1 Already the ancient Greeks… 
Sepsis was known already to the Greeks 4000 years ago. The word “sepsis” is 
Greek and means “to rot”. It was mainly used for skin and soft tissue infections 
causing high fever, foul smelling tissue destruction, weakening of the 
individual and eventually death in just a few days. In modern medicine, “a 
septic patient” refers to someone with high fever, rapid breathing, high pulse, 
low blood pressure, vomiting or diarrhea, general weakness, and sometimes an 
altered mental status.  
1.2 Sepsis definitions 
For many decades and for many Swedish doctors, “sepsis” still equals an 
infection where bacteria or their toxins, have spread to the circulation, 
(Cronberg 1986) [8] and can be detected by blood cultures.  
In 1991, an American consensus meeting (Sepsis-1) defined sepsis as the 
systemic inflammatory response syndrome (SIRS) to a confirmed infection 
process [1]. There were four SIRS criteria: heart rate >90/min, respiratory rate 
>20/min, temperature >38 or <36oC and leukocytes >12 or <4 x 109/ml. For 
sepsis diagnosis, a suspicion of infection plus >2/4 of those criteria were 
needed. Detection of bacteria in blood culture was not obligatory. The 
definition focused on inflammation. An overwhelming inflammatory response 
could cause progressive organ dysfunction, and organ dysfunction was 
associated with high case fatality rates (CFR). Sepsis-induced organ 
dysfunction was termed “severe sepsis” and severe sepsis accompanied by 
circulatory failure was as previously termed “septic shock”. Criteria for 
hypotension were defined, but for “hypoperfusion abnormalities” only 
suggested: “Lactic acidosis, acute alteration of mental status, and oliguria.” 
Organ dysfunction was recognized as a progressive event, not dichotomous, 
and studies were called for that could define the progressive organ dysfunction 
observed in many patients with sepsis.  
Soon there were many suggestions for organ dysfunction definitions, among 
those the Multiple Organ Dysfunction Score (MODS) in 1995 [9], the 
Sequential Organ Failure Assessment score (SOFA) in 1996 [10], and the 
Logistic Organ Dysfunction Score (LODS) in 1996 [11]. However, none of 
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these have come into general use, especially not outside the intensive care 
units, outside clinical studies. 
Critique against the SIRS-criteria for being too insensitive and too unspecific, 
led to a second international consensus conference in 2001 (Sepsis-2) [2]. The 
basic definition of sepsis was retained, but the list of sepsis criteria was 
expanded. Still there were no criteria formulated for organ dysfunction in 
severe sepsis. The criteria for hypotension remained from Sepsis-1, and some 
criteria for “early organ dysfunction” were suggested in the expanded list of 
criteria for sepsis. As criteria for severe sepsis, the suggestion was to use the 
MODS or the SOFA-score [2]. In practice, however, the criteria for “early 
organ dysfunction” in the Sepsis-2 document were used in many clinical 
studies to define organ dysfunction in severe sepsis.  
Some clinical studies though, used more strict criteria for organ dysfunction 
than those for “early organ dysfunction” suggested in Sepsis-2. One such study 
was the PROWESS study in 1998-2000 on the efficacy of drotrecogin alfa, 
recombinant human activated protein-C, in treating patients with severe sepsis. 
In the PROWESS study, the criteria for respiratory dysfunction were stricter. 
Instead of PaO2/FiO2 <300 (mm Hg) for respiratory dysfunction, the level 
chosen was PaO2/FiO2 <250 and if the lung was the focus of the infection the 
level was PaO2/FiO2 <200 [12]. In 2012 the Surviving Sepsis Campaign (SSC) 
Guidelines presented dichotomous criteria for organ dysfunction in severe 
sepsis [13], adopting these respiratory criteria. 
It hardly needs saying, that because of this lack of clear-cut criteria for organ 
dysfunction in severe sepsis, different criteria have been used in almost every 
study since 1991, making studies on the epidemiology of severe sepsis difficult 
to compare. 
In 2011 a work group within the Swedish Infectious Disease Society published 
a consensus document together with representatives for the Swedish Intensive 
Care Society, with a definition and criteria of severe sepsis and septic shock 
[3]. This was based on the Sepsis-1 and Sepsis-2 definitions and criteria with 
some exceptions. The main difference was that the Swedish definition did not 
demand >2/4 SIRS criteria for the diagnosis of severe sepsis. A verified 
infection + organ dysfunction was sufficient. Table 1. The second difference 
was that “acute alteration of mental status” was added as an independent 
criterion for severe sepsis, as suggested in Sepsis-1. The third difference was 
that the stricter criteria for respiratory dysfunction, as used for example in the 
PROWESS study, were adopted. Fourthly, only urine output was used for renal 
dysfunction, not creatinine level. 
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Table 1. The 2011 Swedish consensus definition and criteria of severe sepsis 
and septic shock. Adapted from Ljungström [3]. 
Since 2011, This Swedish definition and criteria have been used in the coding 
of severe sepsis according to ICD-10. It has also been used in the Swedish 
quality register for severe sepsis since 2012. The register is for patients who 
within 24 hours of arrival are referred to the ICU. The Swedish criteria, 
however, have never been evaluated in an epidemiological study. 
In 2016, based on new research findings, a new definition of sepsis was 
suggested by the Third International Sepsis Definitions Task force. The 
concept of sepsis as being caused by hyper-inflammation was abandoned. 
Instead, sepsis was defined as “life-threatening organ dysfunction caused by a 
dysregulated host response to infection” (Sepsis-3) [4]. Organ dysfunction was 
incorporated into the very definition of sepsis, and thus the term “severe 
sepsis” is no longer needed. The criterion for sepsis is now +>2 points from 
base-line in the Sequential Organ Dysfunction Score, SOFA-score [10]. Table 
2. This is said to correspond to a case fatality rate of >10% and <2 points to a 
case fatality rate of <5% [4]. 
 
 
Sepsis Suspected infection + >2 SIRS1-criteria 
Severe sepsis Sepsis or documented infection + either hypotension, hypoperfusion 
or organ dysfunction 
 Hypotension Systolic blood pressure <90 mm Hg or mean arterial pressure <70 mm 
Hg 
 Hypoperfusion Blood lactate >3 mmol/l or + >1 mmol/l above the upper reference limit, 
or, base excess <-5 mmol/l 
Organ dysfunction:  
 Respiratory PaO2/FiO2 <33 kPa (corresponding to 86% saturation on air breathing) 
or 
PaO2/FiO2 <27 kPa (corresponding to 78% saturation) if the lung is the 
focus of infection. 
 Renal <0.5 ml urine/kg/2 hours despite adequate volume resuscitation 
 Hematologic Thrombocytes <100 x 106/ml, or INR2 >1.5, or APTT3 >60 seconds 
 Cerebral Acute change of mental status 
 Hepatic Serum bilirubin >45 µmol/l 
Septic shock Persisting hypotension despite adequate volume resuscitation (500-
1000 ml of crystalloid given within 30 minutes)  
plus either hypoperfusion or organ dysfunction 
1SIRS criteria consist of a. Heart rate >90/min. b. Respiratory rate >20/min. c. Temperature >38.00 C or <36.00 C. 
d. Leukocyte count >12.0 x 109/ml or <4.0 x 109/ml or >10% bands. INR, International Normalized Ratio; APTT, 
activated partial thromboplastin time. 
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Table 2. The SOFA score. Modified from Vincent 1999 [5], Singer 2016 [4] 
and Edman-Waller 2017 [14]. 
The definition of septic shock was also changed, so that septic shock is now 
defined as “a subset of sepsis in which underlying circulatory, cellular, and 
metabolic abnormalities are associated with a greater risk of mortality than 
sepsis alone”. The clinical criteria for septic shock were changed to 
“hypotension requiring vasopressor therapy to maintain mean arterial blood 
pressure 65 mm Hg or greater and having a serum lactate level greater than 2 
mmol/L after adequate fluid resuscitation” [6]. 
1.3 Sepsis epidemiology 
A recent review has estimated that there are 27-30 million annual cases of 
sepsis and 6-9 million deaths from sepsis worldwide [15]. Though 
approximations, these figures give an apprehension of the magnitude of the 
problem that sepsis poses.  
There are many pitfalls in describing the epidemiology of severe sepsis in a 
population. Definitions and criteria have changed over time, have not been 
consistently used, and have been applied to different study populations [16].  
Variabel 
SOFA-score 
0 1 2 3 4 
Respiration: 
PaO2/FiO2, kPa 
Corresponding 
saturation SaO2 % 
 
>53 
 
≥96 
 
≤53 
 
<96 
 
≤40 
 
<92 
 
≤27 
 
<79 
 
≤13 
 
<49 
Coagulation: 
Thrombocytes, 
x 109/l 
>150 ≤150 ≤100 ≤50 ≤20 
Liver: 
bilirubin, µmol/l <20 20-32 33-101 102-204 >204 
Hypotension: 
mean arterial 
pressure, MAP ≥70 mm Hg 
<70 
mm Hg 
Dopamin ≤51 
Dobutamin2 
Dopamin >51 
Adrenalin ≤0.11 
Noradrenalin 
≤0.11 
Dopamin >151 
Adrenalin >0.11 
Noradrenalin >0.11 
Levosimendan2 
Vasopressin2 
Cerebral: 
GCS-points 
RLS-points 
 
15 
1 
 
13-14 
2 
 
10-12 
3 
 
6-9 
4-5 
 
3-5 
6-8 
Renal: 
Creatinine µmol/l 
Diures, ml/day 
 
<110 
≥500 
 
110-170 
≥500 
 
171-299 
≥500 
 
300-440 
<500 
 
>440 
<200 
1) Catecholamine doses are given as µg/kg/min. 
2) Regardless of dose. 
FiO2, Fraction of inspired oxygen; PaO2, partial pressure of oxygen; SaO2, arterial oxygen 
saturation; GCS, Glasgow Coma Scale; RLS, Reaction Level Scale. 
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1.3.1 Sepsis incidence 
The incidence of severe sepsis in high-income countries has been explored by 
two main methods, chart-based or code-based. These methods have yielded 
incidences ranging between 3-1,074/100,000 [16]. Lately a third method, 
extracting clinical criteria from electronic health care records, EHRs, has been 
developed for this purpose [17]. The incidence in low-income countries is 
difficult to estimate because of lack of reliable data.  
The chart-based method is considered the “gold standard” for studying sepsis 
incidence [17], since patients are individually evaluated. The drawback is that 
it is very labor intense, useful only for smaller cohorts, and thus rarely used for 
population-based studies. One such study was performed in a twelve month 
period in 2011-2012 by Henriksen, [18] evaluating all patients admitted to the 
medical ED at the University Hospital in Odense, Denmark. Using modified 
Sepsis-2 criteria, they found an incidence of severe sepsis of 457/100,000 
person-years at risk.  
A variant of this method is to perform chart-based population studies based on 
point prevalence data and extrapolating the results. This method was used in a 
study by Mellhammar [19], evaluating all hospitalized patients in southern 
Sweden who had received intravenous antibiotic treatment at four evenly 
distributed dates during the year 2015. Using criteria similar to those of the 
2012 Surviving Sepsis Campaign, they found an annual incidence of severe 
sepsis of 687/100,000 and of Sepsis-3 of 780/100,000. The incidence did not 
differ significantly between the dates studied. 
The most recent study on the incidence of Sepsis-3 in the United states 2009-
2014, compared clinical criteria from EHRs, to code-based abstraction [17] in 
almost 174,000 patients treated with antibiotics. The results in turn were 
evaluated against “gold standard”, which in this study was chart-based point 
prevalence data from 510 randomly chosen EHRs. The incidence using EHR 
data showed 70% concordance with the results of the chart based evaluation, 
but only 32% concordance with the results of code-based abstraction. The 
reported incidence of Sepsis-3 was 6% of all admissions. Using clinical criteria 
from EHR data, no increase in the incidence of sepsis could be demonstrated 
during those 6 years. Using code-based abstraction, the less sensitive method, 
there was an increase in incidence of 13% per year. 
Code-based abstraction is suitable for large patient populations and is the 
method used in most previous American studies. However, the reliability 
depends on the accuracy in coding. One problem is that coding has changed 
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over the years. In the United States, ICD-9 codes were used until 2008, and in 
2003 classification codes for severe sepsis and septic shock were added to ICD-
9. Sweden started using ICD-10 for coding in 1997, but not until 2011 were 
there additional ICD-10 codes for severe sepsis and septic shock.  
Three American studies have used code abstraction on large population groups. 
In a patient cohort from 1995, Angus estimated the overall annual incidence of 
severe sepsis to be 300/100,000 [20]. In a population study from 2000, Martin 
found an incidence of 81/100,000 [21]. In a cohort from 2003, Dombrowsky 
reported an incidence of severe sepsis of 134/100,000 [22]. The abstraction 
methods used in these three studies plus the method used in a study by Wang 
[23] was applied by Gaieski to a population of nearly 40 million 
hospitalizations during a six year period 2004-2009 [24]. This resulted in a 3.5-
fold variation in incidence, between 300-1,031/100,000 depending on the 
method used. However, the annual increase in incidence was 13%, regardless 
of the method used.  
A study exploring the incidence of severe sepsis in Sweden between 1987-
2005 by Wilhems [25] applied the abstraction methods by Angus, [20] Martin, 
[21] and Flaatens [26] to Swedish data. This resulted in an incidence in 2005 
of only 13-47/100,000. In addition, the sepsis populations identified using 
these three methods were almost entirely different. Most likely, this reflects 
poor quality in coding in Sweden rather than a ten-fold lower incidence 
compared to the United States. 
1.3.2 Risk factors for acquiring sepsis 
Age, co-morbidities, male sex, ethnicity, genetic factors, and geographical 
location are known risk factors for acquiring sepsis [27]. The increasing 
incidence with age has been a consistent finding in many studies [17-21, 27, 
28]. Co-morbidities associated with increased risk of sepsis are diabetes 
mellitus, congestive heart failure, chronic pulmonary disease, 
immunosuppression, chronic renal failure, cancer, liver disease [29] and 
chronic alcohol abuse [18, 30]. Male sex is also a risk factor [20, 21, 30], as is 
African-American [29-31], nonwhite [30], and Aboriginal ethnicity [32]. In the 
United States there is more sepsis in the winter season which coincides with 
the Influenza epidemic [29], but the study from Sweden in 2015 by 
Mellhammar found no seasonal variation [19].  
1.3.3 Case fatality in severe sepsis 
As the incidence of severe sepsis varies with definitions used and populations 
studied, so do case fatality rates. In the study by Gaieski [24], the case fatality 
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rate varied two fold, between 15-30%, depending on the method used for code-
abstraction. In a study by Rhee based on clinically defined EHR data, the in-
hospital mortality of Sepsis-3 between the years 2009-2014 was 15.0%, and 
decreased by 3.3% annually [17]. If including those referred to hospice care 
after being treated for severe sepsis, on the average 6.2%, there was no change 
of the annual in-hospital mortality rate. 
A large comprehensive Australian study on patients with severe sepsis treated 
in the ICU, found a decrease of in-hospital mortality from 35-18.4% between 
the years 2000-2012. The decrease was mainly attributed to overall improved 
ICU treatment during this time period [33], since the same decrease could be 
observed in patients with other diagnoses treated in the ICU as well.  
Increasing age was shown to correlate to case fatality in severe sepsis already 
in the study by Angus in 2001 [20], later also by others [21, 27, 28]. The study 
by Martin in 2007 [28] showed age >65 years to be a statistically significant 
independent risk factor for in-hospital mortality.  
The number of dysfunctioning organ systems has in many studies been 
identified as a risk factor for case fatality [34, 35]. 
The type of organism causing severe sepsis also relates to outcome [36]. In 
patients with bacteremia, Staphylococcus aureus is associated with higher case 
fatality rates than bacteremia caused by Escherichia coli [37]. In a large 
international multicenter study on patients treated in ICUs, infections with 
Enterococcus spp., Pseudomonas spp., and Acinetobacter spp., were 
independent risk factors for case fatality [38]. 
In the study by Angus [20], male sex was associated with higher case fatality, 
as shown also in later studies. 
Time to appropriate antibiotic therapy is another factor affecting case fatality 
rates in severe sepsis, which may become more and more important, as multi-
drug resistance is increasing worldwide. An American study on bacteremia in 
ICU-patients found that >24 hours delay to start of effective antibiotic therapy 
was an independent risk factor for case fatality, and was mainly due to bacteria 
with multiple antibiotic resistances [39].  
1.3.4 Long term effects of severe sepsis 
Acute infections may worsen pre-existing chronic diseases, leading to poorer 
long term outcome [27]. Severe sepsis may lead to decreased cognitive and 
autonomous functions [40] as well as to decreased quality of life [41]. Severe 
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sepsis is a long-term risk factor for death. Shapiro [34] found the one-year case 
fatality in patients with severe sepsis to be significantly higher than in those 
who had an infection but not organ dysfunction. This increase in 1-year case 
fatality was even more pronounced in patients with septic shock. A Danish 
study by Storgaard [42] reported that 1 year and even 4 year case fatality rates 
were significantly increased in patients with severe sepsis compared to a 
control group. Similar results were found by the Finnsepsis study group [43].  
1.3.5 Bacteremia 
The incidence and outcome of patients having bacteremia, or “blood stream 
infection” (BSI) is often treated as an entity of its own among patients with 
sepsis, and is therefore evaluated even in this thesis. Bacteremia ranks among 
the seven most common causes of death in North America and several 
European countries [44]. Ever since the dawn of bacteriology in the 19th 
century, detection of pathogenic bacteria in blood has been considered a sign 
of severity, associated with increased case fatality rates. This has repeatedly 
been verified in clinical studies and reviews [44-48]. As severe sepsis, 
bacteremia has been shown to influences long term case fatality rates up to 
twelve years after an episode [48].  
1.3.6 Respiratory tract infections 
In sepsis studies, the respiratory tract is frequently found to be the most 
common focus of infection, and has therefore received special attention in this 
study. The bacteria most commonly found in community acquired pneumonia 
and associated with the highest case fatality rates is Streptococcus pneumoniae, 
followed by Haemophilus influenzae and Mycoplasma pneumoniae, which 
occurs in epidemics with 3-5 year intervals [49]. 
Respiratory viruses may also cause severe disease, the most obvious being 
influenza A and B viruses. Further, by several mechanisms, viral respiratory 
infections enhance colonization and secondary infection by respiratory 
bacteria [50]. One example is pneumonia caused by S. pneumoniae, H. 
influenza or S. aureus following infection with the influenza virus. In daily 
practice, it is often difficult to distinguish whether a patient with pneumonia 
has a bacterial or a viral infection only, or a combination. In clinical cases of 
“clear cut” pneumonia, many clinicians do not even consider the possibility of 
co-infections with virus.  
One reason why it is important to know if a patient has a viral infection is that 
some viral infections, like influenza, may be treated with anti-viral drugs in the 
early phase. Another reason is the need of infection control. Viral infections 
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are highly contagious. These patients are often cared for in wards together with 
other old and frail patients for whom it might be detrimental to have a severe 
viral infection on top of the condition they already have. Another reason is that 
mixed viral-bacterial infections are related to disease severity, as described by 
Voiriot [51].  
1.4 Sepsis is an emergency 
An infection leading to organ dysfunction is an emergency; early identification 
and adequate antibiotic treatment is imperative for reducing case fatality. This 
can be shown for large groups of patients with severe sepsis (Sepsis-2) [52-54] 
and for patients with septic shock [55]. There are conflicting study results, 
where the influence of the time factor on case fatality cannot always be 
verified. Mostly, this is because patient populations are heterogeneous and 
groups studied not large enough to demonstrate a statistically significant 
difference. Apart from time to antibiotic treatment, the outcome in sepsis 
depends on age, co-morbidities, focus of infection, number of dysfunctioning 
organ systems, and on the causing agent, as described in the previous section.  
1.5 Early identification of sepsis patients 
There is strong consensus on the need to recognize sepsis early, so that 
effective antibiotic treatment can be instituted without unnecessary delay. 
Tools used are the medical history, ongoing medication, symptoms, clinical 
signs, vital signs, clinical examination, laboratory parameters, cultures and 
rapid tests for detection of pathogenic microorganisms, and imaging 
techniques.  
One main challenge in diagnosing patients with sepsis is that neither symptoms 
nor changes in vital signs or laboratory parameters are specific for sepsis. 
Another challenge is that sepsis is both a syndrome and a dynamic process 
where not all characteristics of the syndrome appear at the same time in the 
same individual. This means that changes indicating severe sepsis may not be 
present at the time of investigation or sampling. Therefore, repeated 
examinations, most easily done by recognizing symptoms and measurements 
of vital signs, are of great importance.  
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1.6 Clinical markers of sepsis 
Most clinical markers of sepsis, symptoms, vital signs and laboratory 
biomarkers (hereafter referred to only as “biomarkers”), carry both diagnostic 
and prognostic information. To the clinician in the ED, the prime interest is 
the diagnostic information. Is this an infection? Is this an infection that needs 
antibiotic treatment? Is urgent treatment needed? It is also of interest to 
determine whether this is a severe infection or not. Can the patient be 
discharged home or is inpatient care at a ward or ICU indicated? 
A patient arriving with high temperature, high respiratory rate, and lowered 
level of consciousness, displays variables with both diagnostic and prognostic 
information. They tell us that an infection is most likely at hand (high 
temperature), and that antibiotic treatment is urgently called for (high 
respiratory rate and lowered level of consciousness). More specifically, they 
may draw our attention to bacterial meningitis as a possible cause of the 
infection (high fever, lowered level of consciousness). Further, they tell us 
that if this is an infection, the patient has sepsis, since lowered level of 
consciousness in infection is a criterion for Sepsis-3 as well as for severe 
sepsis (as defined in this study). Finally, the lowered level of consciousness 
and the high respiratory rate tell us that this patient has in increased risk of in-
hospital case fatality, and should probably be treated in a special unit. 
Today, many new biomarkers are launched as important diagnostic or 
prognostic biomarkers. However, in most cases there is already much such 
information available in commonly used vital signs and biomarkers. “What 
does this add to the information we already have?” is an important question 
to ask before introducing new biomarkers on the arena. 
1.7 Symptoms of sepsis 
In our study, a 64-year-old woman with Crohn’s disease, hypertension, and 
overweight, arrived at the ED because of sudden onset of severe upper 
abdominal pain, pronounced respiratory distress and high fever. An 
experienced surgeon suspected bowel perforation. He ordered cultures, broad-
spectrum intravenous antibiotics and a computed tomography (CT) scan of the 
abdomen. The patient was then referred to the surgical ward. The CT-scan 
revealed nothing abnormal. Upon arrival to the ward, a nurse discovered that 
the patient had redness of the left lower limb, and she was diagnosed with 
erysipelas. Recovery was rapid and uncomplicated. Blood cultures were 
negative. Apart from respiratory dysfunction, she fulfilled no other criteria for 
either severe sepsis or Sepsis-3. The leg was the focus of infection, not the 
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abdomen or the lungs. Then why did she have such severe pain in the upper 
part of the abdomen? Why such respiratory distress? 
Many speak about the importance of symptoms in early recognition of sepsis. 
An editorial in the New England Journal of Medicine (NEJM) commenting on 
the PROcess study  on septic shock treatment, wrote[56]: 
“The critical role of the clinician in the early recognition of sepsis continues to 
this day to be fundamental to our efforts to improve the rate of survival. 
Identification of the combination of signs and symptoms that make up the 
systemic inflammatory response syndrome (SIRS) in the context of an 
infection allows the astute clinician to recognize the malady” [57]. 
However, which are these “symptoms of sepsis”? If sepsis is a collective term 
for many different acute serious infections, are there any “symptoms of sepsis” 
to look for? Should we not instead examine for symptoms of the focal infection 
causing sepsis? Yet, the immune response in sepsis to an invading organism is 
the same, regardless of the organism or the focus of the infection. Thus, there 
are good reasons to believe that there really are “symptoms of sepsis”, “fever” 
being the most obvious. Until very recently there have been no studies on this 
topic. 
Why are symptoms important? Because symptoms cause patients with acute 
medical conditions to seek medical care. “Listen to your patient, he is telling 
you the diagnosis”, is maybe the most well-known saying by Sir William 
Osler, “the founding father of modern medicine” [58]. When doctors had less 
technological support, they had to rely more on the patient history and their 
clinical investigation than we often do today. This is still true in poor-resource 
settings. Maybe we are focusing too heavily on changes in vital signs and 
laboratory parameters in making a diagnosis? 
There is a detailed description with many interesting observations from 1852 
by James Hudson Taylor [59] of what we today would call “sepsis” (with organ 
dysfunction). Hudson Taylor, then 20 years old, wanted to become a 
missionary to inland China, until then a country closed to foreigners. The way 
to being accepted in China was by becoming a doctor. Thus, he started studying 
medicine at the Royal College of Surgeons in London, where he was staying 
with an uncle. One night at home while sewing, he accidentally pricked the 
first finger of his right hand, “but in a few moments forgot all about it”. The 
next morning the students started dissecting as before. “The body was that of 
a person who had died of fever, and was more than usually disagreeable and 
dangerous. I need scarcely say that those of us who were at work upon it  
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Figure 1. James Hudson Taylor in England at the age of 20 and at the age of around 70 
when he resided in China. Published with permission of the OMF, Overseas Missionary 
Fellowship www.omf.org.  
dissected with special care, knowing that the slightest scratch might cost our 
lives. Before the morning was far advanced I began to feel weary, and while 
going through the surgical wards at noon was obliged to run out, being 
suddenly very sick – a most unusual circumstance with med, as I took but little 
food and nothing that could disagree with me”. 
After lunch, the pain in his whole arm and right side became more and more 
intense. He got weaker and weaker until he could no longer hold his pencil, 
realized he could not continue class and went back to the dissecting room to 
clean up before going home. There he met “the demonstrator, himself a skilled 
surgeon”, and asked him about the illness. When describing the symptoms, the 
surgeon replied “Why”, said he, “what has happened is clear enough. You must 
have cut yourself in dissecting, and this is a case of malignant fever”. He 
advised me to take a hansom, drive home as fast as I could and arrange my 
affairs forthwith: “For”, said he, “you are a dead man”. By that time the 
young student was unable to walk all the way home and finally had to take a 
ride with an Omnibus. At home, “the pain was very severe. I fainted away, and 
was so long unconscious that when I came to myself I found I had been carried 
to bed”. “Days and weeks passed by” before he was able to leave bed. 
However, he did survive, and made it to China where he died at the age of 73 
years. The full recount is found in the Appendix.  
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This is a vivid description of what most probably was a streptococcal infection, 
a common cause of death in those days. Apart from fever, the symptoms he 
mentions are “severe pain” (in his whole right side), muscle weakness (unable 
to walk home), gastrointestinal upset (vomiting), and unconsciousness. It is 
interesting that when “describing the symptoms”, the demonstrator could both 
diagnose the sickness (“malignant fever”) and give a prognosis (“you are a 
dead man”).  
Which is the pathophysiological basis for these symptoms? All symptoms in 
acute infections are caused by the systemic inflammatory response, 
orchestrated by cytokines and other mediators, many of which, at high 
concentrations, also have other biological effects. Disease severity is related to 
cytokine levels, so it is reasonable to believe that the intensity of symptoms is 
as well.  
Fever is caused by pro-inflammatory cytokines or bacterial components 
increasing the temperature level in the thermostat in the hypothalamus. The 
body tries to adjust to the new temperature setting, often by initiating muscle 
contractions known as “rigors” or “shivering”. The end result is increased body 
temperature, fever [60, 61].  
Acute cerebral dysfunction is a severe symptom in patients with sepsis, 
associated with increased CFRs. The pathophysiology is multifactorial, 
including excessive microglial activation, impaired cerebral perfusion, blood–
brain-barrier dysfunction, and altered neurotransmission [62].  
Dyspnea is a result of increased vascular leakage of fluid into the lung tissue, 
as part of the systemic inflammatory reaction to an infection. This leads to 
increased compliance and a need to breathe harder to satisfy the requirement 
of oxygen. When fluid starts filling the alveoli, saturation decreases. Taken 
together, this causes heavier breathing and decreased saturation which the 
patient experiences as dyspnea [63].  
The acute muscular weakness observed in septic patients is caused by 
excessive production of pro-inflammatory cytokines, hampering muscle 
contraction at several sub-cellular levels [64]. This affects both skeletal 
muscles, but also the muscle of the heart and the intestinal smooth muscles. In 
younger persons, the effect is a decreased ability to perform more heavy 
exercise, whereas elderly patients may be unable to either stand or walk. The 
effect on the heart can be visualized by ultracardiography as dilatation of the 
myocardium and decreased ejection fraction. Decreased smooth-muscle 
contractions in the bowels may result in paralytic ileus. 
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Vomiting and/or diarrhea are symptoms mainly seen in abdominal infections, 
but may occur also in infections unrelated to an abdominal focus. The same is 
true for severe localized pain, which is mostly a sign of the focal infection but 
may be seemingly unrelated to the focus of the acute infection. Though 
mechanisms are manifold, these symptoms are common in patients with sepsis. 
One illustration of this is the well-known case of Rory Staunton, a 12-year old 
boy in New York, who fell ill with fever, vomiting and severe pain in his right 
leg. The pediatrician diagnosed him with gastroenteritis and dehydration, when 
actually he had a streptococcal bacteremia, from which he succumbed. 
Afterwards, his mother pointed out that it was the severe pain in his leg that 
was the main problem, not the fever or the vomiting [65]. The tragic death of 
Rory Staunton led the governor of New York in 2013 to introduce Rory’s 
Regulations, demanding that all hospitals in New York implement routines in 
order to recognize and treat sepsis early.  
1.8 Vital signs in sepsis 
1.8.1 Vital signs in general 
Vital signs are rapidly and easily measured by all health care personnel, and, 
compared to laboratory sampling, can be performed repeatedly. Vital signs 
also contain information about organ dysfunction, though not specific for 
sepsis. Studies show that abnormal vital signs can be used to predict in-hospital 
mortality, and thus give a clue to understanding which vital signs and at which 
cut-offs should be a warning sign. In a large consecutive study on vital signs 
in the ED, Buist [66]found unconsciousness to be the strongest predictor of 
case fatality. The second strongest predictor was respiratory rate of >30/minute 
or lowered level of consciousness. 
Vital sign data can thus be used for clinical decision making in emergency care 
and for surveillance of hospitalized patients that may be deteriorating. In 
Sweden, the Rapid Emergency Triage and Treatment System, RETTS, is 
commonly used in the prehospital setting and in many EDs [67]. For 
surveillance purposes in the wards, NEWS, National Early Warning Score, is 
frequently used [68]. The general idea is that the more deviating the vital signs, 
the more serious the condition. This information can be linked to alarm systems 
to call for extra help if a patient is deteriorating. There are several other systems 
used, but few have been evaluated specifically in their ability to identify 
patients with sepsis. One study by Bayer [69] found the Modified Early 
Warnings Signs, MEWS, score >4 to have a positive predictive value of 0.74 
for sepsis. (MEWS is very similar to NEWS). 
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1.8.2 Vital signs in early identification of patients with 
sepsis 
Fever, an elevated temperature, is the hallmark of infection, and often the key 
to suspecting that symptoms and changes in a patient’s vital signs are caused 
by an infection. Fever is believed to be part of our adaptive response to an 
infection. With increasing temperature, the multiplication rate of many 
bacteria, virus, and fungi decreases and many functions of the immune system 
are activated, such as migration of neutrophils, T-cell proliferation and the 
production of interferon and other cytokines [70]. Yet, far from all patients 
with sepsis or severe sepsis have fever in the ED. In a Swedish study on 
patients with suspected sepsis by Gille-Johnson, only 65% had a temperature 
of >38oC or <36oC on arrival [44]. 
In a pre-hospital setting, Bayer [69] validated vital signs in their ability to 
differentiate patients with sepsis of any severity from patients with non-sepsis. 
They found that each of temperature >38oC or <36oC, heart rate >90/min, 
respiratory rate >22/min, saturation <90%, and systolic blood pressure >90 mm 
Hg, significantly discriminated those with sepsis from those with non-septic 
conditions. Though the study design is commendable, it suffers from a large 
number of dropouts due to missing data, and does not stratify patients 
according to age group. 
To the clinical doctor, it is of prime interest to identify patients with infections 
in need of antibiotic treatment. One study aiming at this by Gille-Johnson [71] 
found the maximum respiratory rate within the first 4 hours after arrival in 
hospital to be the only independent vital sign for this purpose. The median 
respiratory rate for patients with severe sepsis, bacteremia, or infection in need 
of antibiotic treatment, was >24/min. For neither heart rate nor temperature 
was there such a correlation. 
Apart from using single vital signs, there are composite algorithms for sepsis 
identification, based on several vital signs and often some laboratory 
parameter. The SIRS criteria, is one such algorithm, based on the presence of 
>2 of temperature >38 or <36oC, respiratory rate >20/minute, heart rate 
>90/min or leukocyte count >12 or <4 x 109/L. SIRS has been criticized for 
being too insensitive and too unspecific depending on population studied, 
especially patients in the ICU [72]. Yet, in the prehospital setting or in the EDs, 
SIRS may still be a useful tool for identifying patients with an infection that 
might be at risk for developing organ dysfunction [4]. 
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Another composite algorithm for early sepsis identification is the modified 
Robson screening tool. This is based on a medical history indicating infection, 
plus >2/5 criteria similar to the SIRS criteria, adding acute alteration of mental 
state and substituting leukocyte count for blood glucose >6.6 mmol/L in the 
absence of diabetes [73]. Evaluations in pre-hospital use have found a high 
sensitivity for sepsis but a low specificity [69]. It is also considered somewhat 
complicated to use [74]. 
A third composite algorithm for early detection of patients with sepsis is the 
PRESEP score suggested by Bayer [69]. This is a score where each parameter 
has been validated and assigned certain weight: temperature >38oC = 4 points, 
<36oC = 1 point, heart rate >90/min = 2 points, respiratory rate >22/min = 1 
point, saturation <90% = 2 points and systolic blood pressure <90 mm Hg = 2 
points. If a patient has >4 points in the PRESEP score, the sensitivity and 
specificity for sepsis is 0.85 and 0.86 respectively [69] and thus performed 
better than both MEWS and BAS 90-30-90. 
BAS 90-30-90 is a local algorithm used in our own hospital, aiming at 
identifying patients with organ dysfunction. Each parameter in BAS 90-30-90 
targets organ dysfunction, not early changes in vital signs due an infection. The 
idea is that if a patient has a systolic blood pressure of <90 mm Hg, or a 
respiratory rate of >30/minute or <90% saturation by pulse oximeter, the 
patient should be evaluated also for severe sepsis, regardless of temperature or 
whatever other diagnosis is suspected. The rationale is that hypotension is a 
serious sign, an elevated respiratory rate is an early sign and respiratory 
dysfunction is common in severe sepsis. In one study evaluating methods for 
sepsis identification by the emergency medical services, BAS 90-30-90 was 
found to identify 70.4% of the patients with severe sepsis compared to 16% 
clinically suspected by the ambulance nurse [74]. Another study found BAS 
90-30-90 to identify 62% of patients with sepsis of any severity [69]. 
1.8.3 Vital signs in identification of patients with 
sepsis at risk of poor outcome 
Many vital signs are part of the criteria for organ dysfunction and can be used 
for identifying patients in the ED at risk of poor outcome, mostly in-hospital 
mortality. Not surprisingly, patients with an infection and persisting 
hypotension despite adequate fluid resuscitation, septic shock, have the highest 
risk of dying in hospital [34]. Even single organ dysfunction increases the risk 
of in-hospital case fatality, a risk that increases with the number of 
dysfunctioning organ systems [20, 34].  
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Temperature is a vital sign that is not a criterion for organ dysfunction. A recent 
Swedish study on temperature at baseline in patients with severe sepsis treated 
in the ICU, showed a linear inverse relation of temperature to in-hospital case 
fatality rate (CFR) [75]. Patients with temperature <35o C had an in-hospital 
CFR of 50%, whereas those with temperature >40o C had an CFR of only 14%. 
A similar relationship to temperature has also been shown for patients with 
bacteremia [36]. 
Vital signs can also be used in algorithms for predicting in-hospital mortality 
or poor outcome. One such algorithm including vital signs is the mortality in 
emergency department sepsis, MEDS, score [76]. Of vital signs, respiratory 
rate >20/min, saturation <90 %, persisting hypotension (septic shock), and 
altered mental status were independent predictors contributing to the score.  
The most recent predictive scoring system is the qSOFA, quick Sequential 
(sepsis-related) Organ Failure Assessment, score. qSOFA is based on systolic 
blood pressure <100 mm Hg, respiratory rate >22/min or altered mentation. 
The score is positive if two out of the three criteria are fulfilled[77]. A positive 
qSOFA was found in a large derivation and validation study to predict 81% of 
patients with “poor outcome”, defined as in-hospital mortality or >3 days in 
the ICU. qSOFA has been suggested to be used outside the ICU for identifying 
patients at risk that should be assessed for possible sepsis [77]. The usefulness 
of qSOFA has been debated, since not all later studies have been able to show 
the same good predictive ability. A Swedish study by Mellhammar [19] found 
a sensitivity of 55% for predicting severe sepsis and 42% for predicting Sepsis-
3. An Australian study by Williams [35] found a sensitivity of only 29%. 
1.9 Biomarkers in sepsis and severe sepsis 
1.9.1 General comment 
The perfect biomarker for identifying patients with sepsis does not exist. For 
commonly used biomarkers in the clinic, sensitivity and specificity at optimal 
cut-offs rarely exceed 70% [78]. Taking into account the multitude of 
infectious agents with varying pathogenicity that can cause sepsis in patients 
with different age, sex, ethnicity, genetic set-up, co-morbidities, medication 
and patient delay, this is not surprising [79]. More than 180 distinct molecules 
have been assessed for potential use in sepsis [80, 81], but few are in clinical 
use. The majority of these biomarkers have been evaluated as prognostic 
markers; and only ten as diagnostic markers [81]. However, combinations of 
biomarkers may improve sensitivity and specificity for sepsis identification 
[82-84].  
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Whichever biomarkers are available in the clinic, it is important for the 
clinician to know the strengths and weaknesses of the biomarkers used, not 
least the kinetics. Timing of sampling is an important factor. Like a football 
match, sepsis is a highly dynamic process where changes can occur rapidly, 
but, unlike vital signs, biomarkers are not always tested for when the patient is 
the most sick.  
1.9.2 Blood cells in sepsis and severe sepsis 
Sepsis and severe sepsis leads to changes in peripheral blood cell counts and 
distribution, which is often used by clinicians for infection- and sepsis 
diagnosis, mainly white blood cells, but also platelets. In severe sepsis, 
hemoglobin levels go down due to red cell destruction [85], leukocytes 
increase, mainly because neutrophils are released from the bone marrow, and 
platelets decrease because of consumption. There are many studies reporting 
significant changes in size [86, 87], distribution [88] and ratios [89] of different 
cells in sepsis patients. The most commonly used in the clinic are discussed 
below. 
More important than changes in numbers or size of various blood cells, is that 
sepsis or severe sepsis has profound negative effects on the function of almost 
all white blood cells [90], not measured in the lab, but affecting the course and 
outcome in sepsis patients.  
1.9.3 Leukocytes, neutrophils and lymphocytes 
Leukocytes are white blood cells engaged in the immune system. In peripheral 
blood more than 100 different populations can be distinguished by molecular 
markers [91]. The most commonly found leukocyte is the polymorph nuclear 
neutrophil, PMN, or simply “neutrophil”. The neutrophil count in peripheral 
blood can increase as the result of any acute inflammatory process, so it is not 
specific for bacterial infections. Yet, leukocytosis or neutrophilia is often used 
for diagnosing bacterial infections. Neutrophils adhering to the vascular cell 
walls are rapidly mobilized on stimulation by an infectious agent and more 
neutrophils are then recruited from the bone marrow. In experimental 
inflammation, this is seen within 1-2 hours after injecting lipopolysaccharides 
subcutaneously in healthy volunteers [92], and maximum levels are seen 
within 4-6 hours. However, in most studies, not more than half the patients 
with bacterial severe sepsis have leukocytosis or neutrophilia. Leukopenia or 
neutropenia occurs in a few percent of those patients and is generally regarded 
as a less favorable prognostic sign. 
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As neutrophil counts often increase in inflammatory events, lymphocyte 
counts decrease equally rapid [92], and this decrease is generally more 
pronounced in severe sepsis. In sepsis patients this occurs among lymphocytes 
in all tissues, but in non-infectious inflammation only in peripheral blood [93]. 
The decrease in peripheral blood is due to both re-distribution of lymphocytes 
back to the tissues, but even more to induced apoptosis, which eventually leads 
to immune suppression and increased risk of secondary infections with less 
pathogenic bacteria [93, 94]. In the individual septic patient, the degree of 
lymphocytopenia is directly related to the intensity of the infection and to 
outcome, especially if not normalized in 4-6 days [95]. The lymphocytopenia 
in septic shock may even be a main component of sepsis induced immune 
dysfunction [95].  
1.9.4 The neutrophil to lymphocyte count ratio 
The fact that neutrophils rapidly increase in bacterial infections and that 
lymphocytes rapidly decrease [92], can be used in a ratio, the neutrophil to 
lymphocyte count ratio (NLCR) as a measure of acute systemic inflammation. 
This was first described by Zahorec in 2001 [96]. In 2010, deJaeger found the 
NLCR to be useful for identifying patients with bacteremia [89] and later also 
Lowsby [97]. The NLCR was shown by deJaeger to identify patients with 
severe disease and risk of poor outcome in community acquired pneumonia, 
CAP [98]. Recently, Naess found the NLCR to be a diagnostic tool, not only 
for patients having bacteremia, but also having bacterial infection [99]. 
Though useful for detecting patients with bacteremia and severe pneumonia, 
the NLCR has limitations. Sensitivity for bacteremia is at best 70% at a cut-off 
of >10 [89]. In my own experience, the NLCR is not specific for bacterial 
infections. Values >10 can be seen also in viral infections, such as influenza or 
norovirus infections. Probably, the NLCR reaches the highest levels when the 
inflammatory response is the most intense, mainly in the early phase of an 
infection, and then gradually returns to normal as the inflammatory reaction 
subsides. This was described by Naess [99], who found lower levels of the 
NLCR in patients with fever for >1 week compared to <1 week. This is in 
accordance with our clinical experience. 
What about patients without infection? In a master thesis in medicine at the 
University of Gothenburg, Landgren, investigated the NLCR in almost 900 
patients in the medical ED, and found a median value of 4. Very few patients 
with chest pain, angina pectoris, acute myocardial infarction, pulmonary 
embolism or congestive heart failure had a NLCR >10 (unpublished data). 
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In clinical studies, lymphocytopenia performs even slightly better than the 
NLCR in identifying patients with bacteremia [89, 100], but maybe a high 
value (NLCR) is more didactic than a low value for lymphocyte counts. 
However, using both parameter can be of even greater help than only 
evaluating only one of these. 
1.9.5 Platelets (thrombocytes) 
“Platelets are small circulating anucleate cells that are of crucial importance in 
haemostasis. Over the last decade, it has become increasingly clear that 
platelets play an important role in inflammation and can influence both innate 
and adaptive immunity. Dysbalanced immune response and activation of the 
coagulation system during sepsis are fundamental events leading to sepsis 
complications and organ failure. Platelets, being major effector cells in both 
haemostasis and inflammation, are involved in sepsis pathogenesis and 
contribute to sepsis complications. Platelets catalyse the development of 
hyperinflammation, disseminated intravascular coagulation and 
microthrombosis, and subsequently contribute to multiple organ failure. 
Inappropriate accumulation and activity of platelets are key events in the 
development of sepsis-related complications such as acute lung injury and 
acute kidney injury. Platelet activation readouts could serve as biomarkers for 
early sepsis recognition; inhibition of platelets in septic patients seems like an 
important target for immune-modulating therapy and appears promising based 
on animal models and retrospective human studies”[101]. 
In clinical practice, thrombocytopenia occurs as an effect of an activated 
coagulation in sepsis, and is usually seen a few days after onset of a severe 
infection. However, in certain infections, as meningococcemia, 
thrombocytopenia may be present within few hours after start of symptoms. A 
thrombocyte level of <100 x 106/L caused by an infection is one of the criteria 
for organ dysfunction in both severe sepsis and Sepsis-3.  
1.9.6 Coagulation 
Coagulation is an intrinsic part of our local defense mechanisms against 
infections that interacts closely with platelets. In sepsis, there is almost 
invariably a systemic activation of the coagulation system. Normally this is not 
harmful, but may in severe cases lead to intravascular coagulation, causing 
microthrombosis in all major organs. This contributes to organ dysfunction and 
circulatory disturbances often seen in severe sepsis. If pronounced, these 
changes may lead to disseminated intravascular coagulation, DIC [102], which 
can cause both thrombosis and bleedings and is associated with increased 
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CFRs. Currently, the best treatment for DIC in patients with sepsis is treating 
the infection, but in a near future there may be specific treatment options [103]. 
1.9.7 C-reactive protein 
The C-reactive protein, CRP, is an acute phase reactant originating from the 
liver. The CRP binds to the surface of bacteria and injured cells, facilitating 
phagocytosis by macrophages. The production of CRP is stimulated by 
cytokines, mainly interleukin-6, secreted by macrophages and T-cells, which 
can be activated by a wide range of inflammatory conditions such as infections, 
inflammatory diseases, malignancies and traumatic tissue injury. Thus, it is not 
specific for infection, but studies have shown CRP production to be more 
pronounced in bacterial infections than in other inflammatory conditions [104]. 
CRP is a rather slow biomarker. After activation by a bacterial infection, it 
takes 6-8 hours before CRP can be measured in plasma and 24-48 hours before 
maximum concentrations are reached [92]. Therefore, in patients arriving in 
hospital few hours after onset of suspected sepsis, CRP is of little use. The 
CRP-level has not been shown to have any prognostic value. 
1.9.8 Procalcitonin 
Procalcitonin (PCT), is a marker of infection and sepsis described in 1993 
[105]. PCT is a peptide and a precursor of calcitonin, a hormone that is 
synthesized by the parafollicular C cells of the thyroid and involved in 
calcium homeostasis. In acute inflammatory disorders, PCT production 
increases rapidly. Elevated plasma levels can be detected within 2-4 hours 
after an insult, reaching peak values within 12-24 hours [106]. It thus reacts 
much faster than the CRP but slower than the NLCR.  
In septic patients, PCT is “regarded as a helpful biomarker for early diagnosis 
in critically ill patients, though the results need to be interpreted in the 
context of medical history, physical examination, and microbiological 
assessment” [107, 108]. PCT has performed well in detecting bacteremia 
[109-111], and has also been used to guide time for antibiotic treatment in the 
ICU [112, 113] and for prognosis [114].  
1.9.9 Lactate 
Lactate may be highly elevated within few hours after disease onset, but the 
elevation may in many other patients occur at a later stage of the disease. Until 
a few years ago, increased lactate in sepsis was thought to be an effect of 
hypoperfusion of tissues, leading to diminished oxygen delivery, anaerobic 
glycolysis and hyperlactatemia. Today we know that hyperlactatemia is also 
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an effect of metabolic dysregulation in sepsis and septic shock. Regardless of 
its origin, hyperlactatemia in sepsis is significantly associated with increased 
CFRs. Conversely, a rapid reduction in lactate level is significantly associated 
with improved survival rates in sepsis and septic shock [115-117]. Increased 
lactate level is one of the severe sepsis criteria, but not one of the criteria for 
sepsis according to the new Sepsis-3 definition. Despite this, lactate can still 
be, and should be, used as a marker of disease severity in sepsis [4]. And, 
lactate is part of the new Sepsis-3 definition of septic shock, which is now 
defined as a plasma lactate >2 mmol/L plus need of vasopressor to maintain a 
mean arterial blood pressure >65 mm Hg [6].  
1.10 Etiology of infection 
In order to give sepsis patients appropriate antimicrobial treatment, it is of 
utmost importance to identify the microorganism(s) causing the infection. This 
may be done in various ways, most commonly by obtaining cultures from the 
suspected focus of the infection, preferably before start of antibiotic treatment. 
In this study, cultures were performed in the laboratory according to accredited 
methods. Today, molecular techniques for more rapid identification of 
microorganisms are being developed, especially techniques based on detecting 
DNA or RNA of microorganisms. Only methods of special relevance for this 
study are commented on in this section. 
1.10.1 Blood culture 
Blood culture is still “gold standard” for detecting bacteria in the blood, though 
molecular methods are under rapid development and might in the near future 
change this view. A significant finding in blood culture carries much useful 
information for the clinician. It not only reveals the pathogen responsible for 
the disease. The pathogen detected gives a clue to what might be the focus of 
the infection, which in turn directs further investigations and procedures. It 
affects the mode and length of antibiotic treatment, and provides an 
antibiogram so that an appropriate antibiotic treatment can be selected. During 
the past ten years, it has been more and more common in Swedish hospitals to 
draw blood cultures before initiating intravenous antibiotic treatment. In our 
hospital, this has been compulsory since 2011. 
Detection of bacteria in blood culture is dependent on the volume of blood 
used. Today, 40 ml from two puncture sites, divided into 4 different bottles, is 
the recommended volume. Lesser volumes significantly decrease the rate of 
positive cultures. Theoretical calculations favor the use of 80 ml blood for 
optimal yield [118]. 
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1.10.2 Nasopharyngeal culture 
Though there are more sophisticated diagnostic methods on respiratory 
specimen, culture from the nasopharynx is a method easy to perform that can 
be used in clinical routine. However, nasopharyngeal culture is generally not 
regarded as proof of etiology in community acquired pneumonia in adults [49]. 
Many accept only detection of pathogens from other compartments, such as 
blood, sputum, trachea (trans-tracheal aspirate), the bronchial tree 
(bronchoalveolar lavage), thorax (pleural effusions, lung biopsies), urine or 
serology. In Swedish tradition, identification of S. pneumoniae in 
nasopharyngeal culture in adults, is regarded as being a rather specific, though 
not very sensitive method for possible etiologic diagnosis of pneumococcal 
pneumonia. 
1.10.3 Nucleic acid-based testing 
Nucleic acid-based amplification techniques, NAATs, for detecting bacteria 
and viruses in patient samples is an evolving diagnostic field with many 
benefits, but also pitfalls. Among advantages are high analytic sensitivity and 
high specificity for the organism aimed at. Other advantages are short 
turnaround time, being faster than culture, and that the analyses can be 
automated and performed in a closed system with no need for a microbiology 
laboratory. Thus, they can be used, and are used, in low-resource settings, in 
some cases with revolutionary results. Yet another advantage is the ability to 
detect microorganisms that are not easily cultured or slow growing. One good 
example is the GeneXpert, used for detection of Mycobacterium tuberculosis 
and rifampicin resistance in sputum samples [119]. A complete analysis takes 
a few hours compared to many weeks for culture. NAATs may also be 
combined with other techniques, increasing the detection rate even more. 
Among disadvantages are the question of clinical significance, lack of 
antibiograms, costs, and that the technique only detects the organisms it is 
designed for.  
One difficulty in using NAATs to investigate blood lies in detecting the minute 
amounts of bacterial DNA among the vast amounts of human DNA. Therefore, 
many NAATs, like PCR or microarray, have been developed for diagnosing 
bacteria in blood cultures that have already turned positive. Other techniques 
are being developed for this purpose, for example mass spectrometry of bottles 
that have signaled positive, Maldi-TOF®. If automated, these methods may 
save some time, but compared to today’s routine in the labs, the gain is 
minimal. Better if methods could identify bacteria directly in whole blood, 
without the need of culture. 
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The first such commercial test was Septifast® by Roche in 2006, a multiplex-
PCR method which detects the eight most commonly found gram-negative 
bacteria, the six most common gram-positive bacteria, the five most common 
Candida species plus Aspergillus. In a review article by Pasqualini [120], the 
Septifast® was compared to blood culture results as gold standard, and was 
found to have 68% sensitivity and 85% specificity. The conclusion was that it 
was difficult to make firm recommendations about the clinical utility of the 
method. Since then, similar tests have appeared on the market, but have not yet 
received broad acceptance among clinical doctors. 
In several studies the findings of bacterial DNA in blood have exceeded the 
findings by blood culture. This has led to the invention of the term “DNAemia” 
[121], suggested to be a significant finding, since these patients have more 
severe disease and more pronounced inflammatory markers than those who are 
DNA-negative. Another explanation may be that in patients with an acute 
inflammatory reaction, bacterial DNA may more easily reach the blood stream 
through leakage from mucosal membranes. At any rate, the concept of 
“DNAemia” has not gained recognition and is not used in clinical practice. 
For respiratory tract infections, multiplex PCR on respiratory specimens have 
greatly improved detection rates, not least of viral infections and difficult-to-
culture bacteria such as Mycoplasma pneumoniae, Bordetella pertussis and 
Chlamydophila pneumophila. Nasopharyngeal specimens are in daily practice 
easily obtained using a swab and universal transport medium, though throat 
swabs, nasopharyngeal aspirates, sputum, trans-tracheal aspirates or 
bronchoalveolar lavage may result in higher yields and higher specificity [122, 
123]. Methodological obstacles lie in the questions of sensitivity and 
specificity – are all relevant viruses detected by this method? Which is the 
analytical sensitivity of the method in detecting the viruses included in the test? 
Are the viruses detected proof of an acute or ongoing infection? For improving 
clinical sensitivity and specificity, serology has been shown to add diagnostic 
value to NAATs in diagnosing several different respiratory viral infections 
[124].  
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2 AIMS 
The epidemiology of sepsis is important for health care planning and resource 
allocation in order to provide the best possible medical care for the population. 
Since code based estimations are inferior, we wanted to perform a prospective 
study using “gold standard” methodology, evaluating patients individually per 
protocol. The manageable size of the population of Skaraborg and the health 
care infrastructure in Sweden provided excellent prerequisites for performing 
such a study. 
The overall aims were  
 To investigate the incidence and epidemiology of community 
onset severe sepsis among adults in the former county of 
Skaraborg in western Sweden. (Study I). 
 To investigate factors affecting outcome in community onset 
severe sepsis in adults in this study population (Study I). 
 To evaluate the performance of the 2011 Swedish consensus 
criteria for severe sepsis (Study 1).  
 To evaluate the new Sepsis-3 definition and criteria launched 
in February 2016 (Study I).  
 To investigate the clinical value of a nucleic acid 
amplification test in early detection of bacteria in whole blood 
on part of the study population (Study II).  
 To investigate the clinical value of nucleic acid amplification 
test in detection of respiratory viruses in nasopharyngeal 
samples on part of the study population (Study III). 
 To evaluate the clinical performance of commonly used 
biomarkers for sepsis identification (Study IV). 
 To evaluate the use of six defined systemic symptoms in early 
identification of severe sepsis in the emergency department. 
(Study V). 
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3 PATIENTS AND METHODS 
3.1 PATIENTS 
3.1.1 Studies I-IV. 
The epidemiological study was conducted in the former county of Skaraborg, 
since 1998 part of Region Västra Götaland in western Sweden. The region has 
a population of about 1.6 million, the main city being Gothenburg. Skaraborg 
is a rural area, with a population of 256,700 by Jan 1 2012, 206,900 being 
adults. Skaraborg has one public secondary care hospital in two locations, 
Lidköping and Skövde. In Sweden, there is open access to all hospitals. For 
admitted patients, medical care is free of charge, apart from a small daily 
administrative fee. 
Skaraborg hospital has approximately 640 beds, 60,000 annual visits to the 
emergency department (ED), and 24,000 admissions. During the study period, 
one electronic patient record, Melior (Siemens), was used throughout the 
hospital. Unilabs, an accredited private laboratory, served the hospital with 
laboratory diagnostics in both clinical chemistry and clinical microbiology. 
Unilabs performed all routine laboratory analyses on patient samples included 
in this study. The Emergency Medical Services, EMS, is public and the same 
throughout Skaraborg. The EMS used a separate electronic patient record, 
AmbuLink, for medical history and vital signs, available through the hospital 
electronic patient record. The EMS and the ED used the same triage system, 
Rapid Emergency Triage and Treatment System, (RETTS) [67], which 
included documentation of vital signs. Both electronic patient records were 
used for retrieving information on patient medical history, vital signs, results 
of biochemistry, cultures, and imaging, in order to assess the presence or 
development of severe sepsis or septic shock. 
During a 9 month period, September 8, 2011 – June 7, 2012, all adult 
permanent residents of Skaraborg, admitted to the hospital and within 48 hours 
started on intravenous antibiotic treatment on clinical suspicion of a bacterial 
infection, were evaluated for presence or development of severe sepsis or 
septic shock during the first 48 hours. (Study I). All admissions were evaluated, 
but incidence and 28-day case fatality rate (CFR), were calculated using the 
first episode for each patient only. Exclusion criteria were non-residents of 
Skaraborg, re-admissions within 30 days for the same infection, patients with 
post-operative infections within 30 days of surgery and patients who never 
received intravenous antibiotics even though first intended. Figure 2. 
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Figure 2. Patient selection to the study on severe sepsis as well as distribution of patients 
having severe sepsis or Sepsis-3. 28-day CFRs are included. CFR, Case fatality rate. 
Study II–V were performed during parts of Study I. Table 3. 
Table 3. Time periods and locations of the five studies in this thesis. 
 
September 8, 2011 – June 7, 2012 
Visits to the ED
≈ 45,000 
Admission 
≈ 18,000 
Protocols never 
returned -246 
Intravenous 
antibiotic 
treatment 
2,850 (16%) 
Exclusion criteria 
-216 
Admission to 
be evalutated 
2,462 
Included after 
admission + 107 
Individuals 
2,196 
No infection 
134 (6%) 
CFR 
11% 
Severe sepsis 
or septic shock 
429 (20%) 
Sepsis 3 
1,362 (62%) 
CFR 
25% 
CFR 
12% 
Non-severe 
sepsis 
1,633 (74%) 
Not sepsis 3 
700 (32%) 
CFR 
4% 
CFR 
2% 
September 8, 2011 – June 7, 2012 
Sept 8, 2011 Oct 2011 Nov 2011 Dec 2011 Jan 2012 Feb 2012 Mar 2012 Apr 2012 May 2012 June 7, 2012 
Skaraborg Hospital, Lidköping and Skövde  
Study I – Epidemiology and outcome n=2,196 individuals, 2,462 episodes  
      Study II – 
Multiplex PCR on 
whole blood 
n=383   
    Study III – Respiratory  viral 
infections 
n=432   
Study IV – Biomarkers n=1,572 episodes   
Södra Älvsborg Hospital Borås  
      Study V – 
Symptoms 
of sepsis 
n=289   
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3.1.2 Study V. 
The study on symptoms was performed in another population at Södra 
Älvsborg Hospital in Borås, with a catchment area of 190,000 inhabitants. The 
hospital in Borås is also a public secondary care hospital, similar in size to the 
hospital in Skövde, and part of the same region, Region Västra Götaland. The 
study was conducted during the month of March in 2012 on all patients having 
received intravenous antibiotic treatment for a community onset infection.  
3.2 Methods 
When infection needing intravenous antibiotic treatment was suspected on 
admission or within the first 48 hours, the patient and/or a close relative 
received oral and written information about the study by the attending nurse. 
Routine biochemistry taken on arrival consisted of a full hemogram, blood 
neutrophils and lymphocytes, the neutrophil to lymphocyte count ratio 
(NLCR), electrolytes, creatinine, liver enzymes, prothrombin complex, and a 
venous blood gas with lactate. The initial sampling included 1.5 ml plasma and 
3 ml whole blood. If patients or a close relative within 3 days after admission 
gave a written consent to participate in the study, the plasma and whole blood 
was stored at -80o C for later analyses of sepsis biomarkers. Apart from blood 
cultures, all other cultures were performed at the discretion of the attending 
physician. Urine culture was performed in most patients. In patients with 
respiratory symptoms or sepsis with unknown focus, culture from the 
nasopharynx was desired, as was culture from wounds if present.  
For diagnosis of hypoperfusion in severe sepsis, venous lactate was used on 
arrival for routine screening of all patients with suspected sepsis. In many 
severely ill patients, further saturation measurements were preferrably assessed 
in arterial blood. A lactate value >1 mmol/L above the upper reference limit in 
venous blood, in our lab 0.9-2.5 mmol/l, was used as a criterion for 
hypoperfusion. For respiratory dysfunction, saturation measurements of 
oxygen saturation (SpO2) were routinely assessed using pulse oximetry. The 
correlation to saturation assessed in arterial blood is debated, different studies 
showing different results, but in patients with severe sepsis there seems to be 
a tendency for pulse oximetry to overestimate the saturation in arterial blood 
(SaO2) [125]. In patients receiving supplementary oxygen, saturation values by 
pulse oximetry were corrected for using the FiO2 values for supplementary 
oxygen found in the Swedish Intensive Care Register (SIR). For cerebral 
dysfunction, the Reaction Level Scale (RLS) was used instead of the Glasgow 
Coma Scale (GCS), since RLS is the method used by the EMS and in the triage 
in the ED in our hospital.  
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During the study period, the laboratory delivered two lists on a daily basis; one 
list of all patients who had study samples taken during the past 24 hours and 
one list of all blood cultures drawn within the past 24 hours. On weekdays, a 
study nurse would take the lists and visit the patients in the wards to repeat 
information about the study, answer questions about the study if any, and to 
collect written consent. After 3 days in the ward or more, the study protocols 
were returned by the internal mail to the Infectious Disease Clinic for 
evaluation by either of the study doctors LL or GJ. Patients who had not 
consented to participate in the study were evaluated anonymously for 
epidemiological data only. Severe sepsis or septic shock was diagnosed using 
the 2011 Swedish consensus definition and criteria for severe sepsis and septic 
shock. The protocols were entered into an IBM SPSS database version 22.0 
(Inc, Chicago, IL) by a secretary at the Skaraborg Hospital Research and 
Development Center. Later, after the launch in February 2016 of the new 
Sepsis-3 definition and criteria of sepsis, the study cohort was evaluated also 
according to Sepsis-3[4]. 
We thus chose to include patients admitted and within 48 hours started on 
intravenous antibiotic treatment, according to the definition of community 
onset infection. Since inclusion depended on the attending nurse, some patients 
may have been missed to be included. To analyze the rate of patients missed, 
we analyzed a list of patients during the study period who had a significant 
finding in blood culture. That way we found 30 patients who had been missed 
to be included. For the month of March 2012 we obtained a list from the EHR 
of patients who had received intravenous antibiotic treatment within 48 hours 
of admission. Comparison with study patients revealed that 23/343 (7%) of 
admissions had been missed to be included in the study.  
This study method, chart-based or protocol-based, is considered “gold 
standard” but is very labor intense and suited only for a smaller hospital where 
almost all patients can be surveilled. Through the Swedish unique 
identification number, every study patient could easily be retrieved in the 
EMS- and hospital EHR. That way all vital signs and laboratory values could 
be accessed, and no patients were lost to follow-up. 
Today, there is an EHR-linked, online-based, hospital developed, program, 
“the infection tool” where all antibiotic prescriptions in hospitals are 
compulsory registered. This allows for rapid access to all patients who have 
received any antibiotic treatment and for whatever reason. The “infection tool” 
was used in the study by Mellhammar [19], though in a point prevalence 
fashion. This method is probably well suited for future studies on sepsis 
epidemiology, and can also include hospital acquired infections. 
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Did we miss other patients? Obviously we could have missed patients with 
community onset sepsis who were diagnosed more than 48 hours after 
admission, but we believe those were few. If missed altogether, they would 
probably not survive a severe infection. One way of identifying such patients 
could be to review the EHRs of all patients who died during the stay in hospital. 
Another group of patients probably missed were those with acute infections 
who never sought medical care or patients in nursing homes who were never 
referred to hospital because of some concomitant terminal illness. There were 
most certainly such patients, but the extent was difficult to determine, since 
they were not subject to diagnostic efforts. Thus, our results should be regarded 
as a minimum. 
Did we diagnose correctly? In the Swedish definition, “acute alteration of 
mental status” is one criterion of severe sepsis. We used RLS >2, since this is 
the scale used in our triage system RETTS. That way we probably missed some 
patients, since not all who had an acutely altered mental status were considered 
to be RLS 2. This is a question of training, since most personnel in the EDs are 
not trained to either ask for or to document “acute change of mental status”. 
How accurately does oxygen saturation by pulse oximetry reflect the oxygen 
concentration in blood? In a Canadian study on patients with severe sepsis, 
pulse oximetry was found to overestimate the arterial oxygen saturation by 
2.75%, even more in the presence of hypoxemia [125]. How accurate is the 
estimation of the inhaled fraction of oxygen in patients receiving 
supplementary oxygen treatment? How much can venous lactate 
measurements be trusted compared to arterial measurements? Does 
medication, like metformin, affect the lactate levels in patients with diabetes 
mellitus? Methodological problems like those mentioned may well have 
affected the outcome of this study, but are difficult to answer. Nevertheless, 
the results obtained with the method used did separate patients with a high CFR 
from those with a low and therefore seems useful in a Swedish setting. 
Did we miss any risk factor? Chronic alcohol abuse is a known but probably 
underestimated risk factor for acquiring infections such as pneumonia and 
bacteremia [30]. Since information on a patient’s alcohol consumption is often 
lacking in our EHRs and since biomarkers for alcohol consumption is not 
routinely measured, we could not evaluate alcohol as a risk factor in our study. 
This, however, was done in a Danish study by Henriksen [18], who found that 
10% of cases of severe sepsis and 20% of cases of septic shock were alcohol 
related. 
The study on symptoms, Paper V, was performed in Borås (see 3.1.2). Patients 
were identified using Sjukhusets Antibiotika- och Infektionsuppföljnings-
system (SAI), Neotide, Vasa, Finland. SAI is a Windows-based on-line tool 
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for hospital antibiotic use and infection control that is linked to the electronic 
healthcare record and automatically registers all antibiotic prescriptions. Using 
chart-based method, patients identified were retrospectively evaluated for 
severe sepsis according to the Swedish 2011 definition and criteria. 
3.3 Statistical analysis 
Statistics used in the different studies are described in detail in the different 
papers. In study III on respiratory tract viral infections, only descriptive 
statistics were used. 
3.4 Ethics 
The study in Skaraborg on sepsis epidemiology, characteristics and outcome 
(papers I-IV), was approved by the regional ethical review board in 
Gothenburg, reference number 376/11. 
The study on symptoms of sepsis conducted in Borås (study V), was approved 
by the regional ethical review board in Gothenburg, reference number 617-14. 
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4 RESULTS AND DISCUSSION 
4.1 Paper I. Epidemiology and outcome of 
severe sepsis 
Using the 2011 Swedish consensus criteria, we found an incidence of 
community onset severe sepsis and septic shock of 276/100,000. This is lower 
than in contemporary chart-based studies from Denmark and Sweden. The 
Danish study by Henriksen [18] used saturation <92% as criterion for severe 
sepsis, which probably accounts for the higher incidence in their study, 
457/100,000. The Swedish study by Mellhammar [19] investigated both 
community onset and hospital acquired severe sepsis, and found an incidence 
of 687/100,000. They used a 4-day point prevalence evaluation and 
extrapolated the results for the year of 2015, which may account for some of 
the difference.  
The incidence of Sepsis-3 in our study was high, 878/100,000, in the same 
range as reported by Mellhammar [19]. This incidence was three times as high 
as that of severe sepsis. The reason was mainly the high proportion of patients 
having >2 points in SOFA score for respiratory dysfunction. Still, this may 
have been an underestimation of the incidence, since using pulse oximetry for 
measuring oxygen saturation has a tendency to yield higher values than the 
actual saturation measured in arterial blood [125]. 
When comparing the two sets of criteria for organ dysfunction, we found that 
the Swedish 2011 criteria identified a smaller cohort with a 28-day case fatality 
rate (CFR) of 25%, and the Sepsis-3 criteria a more than three times as large 
cohort with a 12% 28-day CFR. Those who did not have severe sepsis had a 
28-day CFR of only 4%. Figure 3. Thus the Swedish 2011 criteria were able 
to distinguish patients with a high 28-day CFR from those with a low, not much 
higher than that of the general hospital population. We retrospectively applied 
Sepsis-3 criteria to the study cohort of 2,196 individuals. Of the 429 patients 
with severe sepsis, 413 (97%) also fulfilled the Sepsis-3 criteria, as did 949 of 
those not having severe sepsis according to Sepsis-2. The additional 949 
patients that also fulfilled the Sepsis-3 criteria had the same average age, 78 
years, as those with severe sepsis, but had a 28-day CFR of only 6%, so that 
the 28-day CFR in the Sepsis-3 group dropped to 12%. This shift led to a drop 
in average age in the non-Sepsis-3 group from 67 to 60 years and to a 28-day 
CFR of only 2%. This should serve as a basis for debate among doctors. Do 
we want 2/3 of all admitted patients who receive intravenous antibiotics to be 
diagnosed as “sepsis-patients”? 
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Figure 3. Distribution of patients with severe sepsis according to the Swedish 2011 
criteria and of patients with Sepsis-3 within the study population. Includes 28-day CFRs 
for the different groups. CFR, case fatality rate. 
In our study, the most common organ dysfunction in severe sepsis was 
hypoperfusion, due to increased lactate levels, in 52% of the patients. This rate 
is more than twice as high as in most other studies. One reason may have been 
the high median age of our study population, 58% being >75 years of age. 
Another may have been the high rate of venous lactate taken on arrival in the 
ED, 93%. However, in a recent large American study by Rhee of nearly 
174,000 patients with Sepsis-3 during the years 2009-2014, the most common 
organ dysfunction was also an increased lactate, in 52% of the patients [17]. 
An interesting observation in this study was that the rate of some organ 
dysfunctions was constant regardless of age group, whereas respiratory 
dysfunction and to some extent cerebral dysfunction increased with increasing 
age. Figure 4. 
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Community onset sepsis in Sweden 
34 
Figure 4. Rates of organ dysfunction in 482 episodes of severe sepsis relative to age 
groups. 
Maybe more interesting was the influence of age, both on incidence and case 
fatality rates. These findings are not new (section 1.3.1 and 1.3.3), but maybe 
not highlighted as they should. The incidence increased about 40-fold between 
the youngest and the oldest age groups, for both severe sepsis and Sepsis-3. 
The 28-day CFR increased about 10-fold between the youngest and the oldest 
age groups, for both severe sepsis and Sepsis-3. Below the age of 50 years, 
severe sepsis was a rare event and the 28-day CFR was low. Above the age of 
65 years, the incidence was 30-40% higher in men than in women, but the 28-
day CFR was not higher in men. Figure 5. (see Supplement 1, Table, Paper I).  
Figure 5. Incidence and 28-day case fatality rates from severe sepsis and sepsis-3 in men 
and women in different age groups 
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In sepsis studies, incidence and case fatality rates are often presented for whole 
populations. However, the age distribution should always be accounted for, 
since it highly affects both parameters.  
The average co-morbidities per age group were rather constant in the age 
groups >65 years, even slightly lower in the >85 year group. The average of 
organ dysfunctions in those who died was also rather constant, around 2.5 in 
all age groups >65 years. If co-morbidities do not increase with age, why does 
the incidence increase? Is the explanation to be found in the impaired function 
of the immune system that comes with age [126, 127]? Is this “a hidden co-
morbidity” present in many elderly patients that we are unaware of, since it is 
not as easily measured as co-morbidities in other organ systems? 
In the multivariate regression analysis, age >75 years turned out as an 
independent risk factor for 28-day case fatality in those having severe sepsis. 
If the average of organ dysfunctions does not increase with age, why does the 
28-day CFR? Is this a reflection of the profound dysfunction of the immune 
system inflicted upon an immune system compromised by age [90]? Can we 
liken the ageing immune system to an ageing heart and the bout of severe sepsis 
to a myocardial infarction of the immune system with concomitant high CFRs, 
not only within 28 days, but also in many years to come? 
Of vital signs, renal dysfunction, respiratory dysfunction, acute change in 
mental status, and temperature on arrival, were significant risk factors for 28-
day case fatality in patients with severe sepsis. In a Swedish study on patients 
with community onset severe sepsis treated in the ICU, Sundén-Cullberg 
reported an inverse relationship between temperature on arrival and in-hospital 
case fatality rates [75]. This was found also in our population-based study. One 
explanation may be that hypothermia in patients with severe sepsis is an 
indicator of a compromised immune system that is unable to react properly to 
the assault of an invading pathogen [70]. 
The incidence of community onset bacteremia found in this study cohort 
203/100,000 was higher than in another Swedish study from the same time-
period by Holmberg, 156/100,000 [128]. It was high compared to other 
contemporary Scandinavian studies that also included hospital acquired 
bacteremia; Norway 223/100,000 [45], Denmark 199/100,000 (2008) [129], 
and Finland 167/100,000 (2007) [46]. The incidence is higher than in older 
studies in Europe and North America [44, 47] yet this was in community onset 
patients only. The most likely explanation is the high frequency of blood 
cultures drawn in our study, before initiating intravenous antibiotic therapy. 
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Bacteremia, or “blood stream infection”, is often highlighted as a disease of its 
own with high CFRs. The overall 28-day CFR among patients with bacteremia 
in this study was 13%, in the same range as contemporary Scandinavian studies 
[45, 46]. However, we found a co-variation with severe sepsis, linking the 28-
day CFR to organ dysfunction rather than to bacteremia per se. In fact, in the 
severe sepsis group the 28-day CFR was even slightly lower in those who had 
bacteremia compared to those without. In the group having non-severe sepsis, 
the 28-day CFR was also slightly lower among those with bacteremia than 
without. Bacteremia was more common in patients with organ dysfunction 
than in patients without, 25% versus 5 %, but did not increase the 28-day CFR 
in either group. 
Further, like sepsis, bacteremia is not a disease in itself, but rather a term used 
for all bacteria found in blood cultures, having different pathogenicity, 
different concomitant focal infections, and different CFRs. We found that the 
28-day CFR from S. aureus bacteremia was significantly higher than that from 
E. coli bacteremia, though the rate of severe sepsis among those with S. aureus 
infection was lower than among those with E. coli bacteremia.  
This study was performed in a setting with very low frequency of resistance to 
intravenous antibiotics commonly used for treating septic patients. In 93% of 
the patients with bacteremia, the initial treatment was effective and given early 
after arrival in the hospital. Therefore, the CFRs can be regarded as reflecting 
the outcome under rather optimal conditions. The CFRs from bacteremia is 
probably different in countries with higher rates of antibiotic resistance or 
multi-drug resistance, where initial treatment may not always be appropriate.  
The reason why we looked at community onset severe sepsis was mainly 
because we wanted a description of a population that could be extrapolated to 
the whole Swedish population. If we had looked at hospital-acquired sepsis or 
postoperative sepsis as well, it would have been valid only for the situation in 
a secondary care hospital.  
We chose to evaluate all patients that were prescribed intravenous antibiotic 
treatment for a suspected bacterial infection. This method has been used in 
other studies as well, for example by Rhee [17] and Mellhammar [19]. This 
way we missed some patients, whom we found when we retrospectively 
compared our study patients with a list form the electronic health record of 
patients who had received intravenous antibiotic treatment within 48 hours of 
arrival. This latter method would have been a better way to find the patients 
we wanted to study, but such lists were not readily available and did not 
indicate whether the antibiotic given was for treatment or for prophylaxis.  
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4.2 Paper II. Multiplex-PCR on whole blood 
In this study, we primarily evaluated the clinical significance of findings by a 
commercial multiplex PCR test for bacteria on whole blood, Magiplex™ 
Sepsis Real-Time Test. The results were compared to the results of blood 
culture, still regarded as “gold standard”, despite known incomplete 
sensitivity. The laboratory work was performed by Unilabs Department of 
Clinical Molecular Biology. During a six week period of the epidemiological 
sepsis study, patient blood from 383 consecutive episodes of suspected sepsis 
was tested. An algorithm was developed for interpretation of the findings by 
either method, Figure 6.  
Figure 6. Algorithm for deciding on clinical relevance of microbial findings in blood by 
blood culture [130] or NAAT. Other cultures were made from clinically relevant sites 
before administration of intravenous antibiotics. On suspicion of pneumonia or sepsis 
with unknown focus, a pulmonary X-ray was performed. Ultrasound, computed 
tomography scan, and magnetic resonance imaging were used when deemed necessary 
for diagnosing the site of infection. BC blood culture; NAAT nucleic acid amplification 
test. Adapted from [131]. 
Blood culture yielded 43 clinically relevant findings. Of those, 22 were 
identified also by the multiplex PCR, but 21 were not. The main reason the 
multiplex PCR did not detect all bacteria found by blood culture may be the 
amount of blood used for the different methods, 1 ml for multiplex PCR and 
40 ml for culture. On the other hand, the multiplex PCR identified 34 
microorganisms not detected by blood culture. Of those, five were consistent 
with both the clinical diagnosis and bacteria cultured from the suspected site 
of the infection, and was therefore regarded as proven etiology. Ten were 
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regarded as possible etiology, since they were consistent with the clinical 
diagnosis, though not found in any other culture. The remaining 19 were 
regarded as “findings of unknown significance, since they did not correlate to 
the final clinical or bacterial diagnosis.  
The conclusion was that the sensitivity of blood culture could be enhanced by 
adding the findings of a commercially available multiplex-PCR test, despite 
the much lower blood volume used. If the analytical sensitivity of the PCR is 
improved and if the DNA extraction methods are developed to allow testing 
on larger volumes of blood, findings by multiplex PCR will probably increase. 
However, since the multiplex PCR also identifies microbial agents that do not 
fit into the clinical picture, the results must be interpreted with caution and in 
light of the clinical diagnosis.  
This multiplex PCR test was labor intense, but improved and automated 
versions are already on the market. Present drawbacks with the method are the 
lack of antibiotic susceptibility pattern and high costs. 
4.3 Paper III. Respiratory viral infections 
In this study, we evaluated the clinical significance of findings by two 
commercial multiplex PCR tests for respiratory viruses. The results were 
compared to the results of nasopharyngeal culture as well as to the clinical 
diagnosis. The laboratory work was performed by Unilabs Department of 
Clinical Molecular Biology.  
During 13 weeks of the winter season, January – March 2012, we examined 
nasopharyngeal samples from 432 consecutive patients having a suspected 
respiratory tract infection or sepsis with unknown focus. By culture, bacteria 
were detected in 104 patients. By multiplex PCR, 166 viruses were detected in 
158 patients and Mycoplasma pneumoniae was detected in another 5. In 50 
patients, there was a mixed finding of both bacteria and respiratory virus. The 
most commonly found respiratory virus was influenza A virus (n=96), 
followed by human metapneumovirus (n=23), coronaviruses (n=19) and 
respiratory syncytial virus A and B (n=12). 
We found respiratory viral infections to be more than twice as common as 
clinicians suspected. The clinical significance of this in individual cases is not 
presented in the paper, but could be described in terms of “cognitive errors”. 
Some examples:  
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A middle aged man with sequels after a traumatic brain injury arrived with 
fever and bilateral interstitial pulmonary infiltrates on chest X-ray. 
CRP was moderately elevated. Initial suspicion: Pneumonia. Final 
diagnosis: Aspiration pneumonia, though there was no evidence of 
aspiration. Multiplex PCR: Bocavirus. 
A woman in her forties undergoing chemotherapy for malignancy arrived 
one week after the latest treatment with chills and 40oC temperature. 
Overt respiratory symptoms Initial suspicion: Neutropenic fever. 
Multiplex PCR: Influenza A virus. 
An elderly woman who had two weeks previously started medical 
treatment against a hematological disease arrived with dyspnea, fever 
and bilateral interstitial pulmonary infiltrates. CRP was moderately 
elevated, no leukocytosis. Diagnosis: Adverse drug reaction. 
Multiplex PCR: Human metapneumovirus. 
A man in his seventies on medical treatment for a hematologic disease 
arrived with fever since a few days, a mildly sore throat, and 
moderately elevated inflammatory parameters. The only finding was 
E. coli in the nasopharynx. Diagnosis: Pharyngitis caused by E coli. 
Treatment: Ciprofloxacin. Multiplex PCR: Respiratory syncytial 
virus. 
As many as 75% of those with S. pneumoniae and 33% of those with H. 
influenzae in the nasopharynx having new infiltrates on chest X-ray, also had 
a respiratory viral infection. Co-infections are associated with more severe 
disease [51], and in our study, the only two patients under the age of 50 years 
with severe sepsis due to pneumonia needing treatment in the ICU, had 
bacterial-viral co-infections. 
Since nasopharyngeal culture is generally regarded as a non-reliable method 
for etiological diagnosis of pneumonia, we had no a priori expectations of 
detecting any correlation. Therefore, it was an unexpected finding to see the 
seemingly convincing correlation between nasopharyngeal findings of S. 
pneumoniae or H. influenzae and X-ray verified pneumonia. In this cohort of 
patients with suspected sepsis, these bacteria were rarely found in patients not 
having pneumonia and not found at all in patients with no respiratory tract 
infection. Numbers were small and no far-reaching conclusions should be 
drawn, but the results do indicate an acceptable clinical value of 
nasopharyngeal culture for etiological diagnosis of pneumonia caused by S. 
pneumoniae and H. influenzae. 
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Asymptomatic carriage of S. pneumoniae in adults is uncommon. Gunnarsson 
[130] found S. pneumoniae in only 1% of Swedish adults. In a Swedish study 
on pneumonia etiology, Hedlund [131] found a high specificity of 
nasopharyngeal culture positive for S. pneumoniae to detection by other 
methods. In their study, 121 patients were diagnosed as having pneumonia 
caused by S. pneumoniae by other methods. Of those, 33 (27%) also had a 
positive culture of S. pneumoniae from the nasopharynx. If patients having 
been treated with antibiotics prior to culture were excluded, the diagnostic 
sensitivity increased to 36%. In another study on the etiology of pneumonia, 
Stråhlin [123] found that detection of H. influenzae in the nasopharynx showed 
good correlation to other diagnostic methods. 
During the winter season, more frequent testing for respiratory viruses in 
patients admitted for infection with a respiratory focus or unknown focus could 
improve infection control measures and help doctors realize the contribution 
of viral infections to the many times complex and severe clinical picture. In 
patients arriving in hospital early in the course of the disease, antiviral 
treatment may also be beneficial. 
4.4 Paper IV. Biomarkers in sepsis 
This study was performed in co-operation with Unilabs and the Systems 
Biology Research Centre at the University of Skövde. Out of 2,196 patients 
evaluated in the epidemiological study, 1,637 gave a written consent in 1,887 
episodes to participate in evaluation of biomarkers for sepsis. From those 
patients, 1.5 ml plasma had been drawn on admission, before start of 
intravenous antibiotic treatment, and stored at -80oC. Plasma samples from the 
first 1,572 of those episodes were analyzed for procalcitonin and compared 
with study results on admission for C-reactive protein (CRP), the neutrophil to 
lymphocyte count ratio (NLCR) and lactate. Discriminant analysis was used to 
construct two composite biomarkers, one consisting of CRP + NLCR + lactate 
and the other of all four biomarkers. Results were evaluated according to the 
Swedish 2011 criteria (Sepsis-2), for Sepsis-3 criteria and for bacteremia. 
Using the Swedish 2011 criteria for proven bacterial infections, the NLCR 
showed the best performance in detecting sepsis of any severity, having an area 
under the receiver operating curve (AUC) of 0.68 (95% CI 0.65-0.71). This 
was equal to the composite biomarkers but better than the other single 
biomarkers.  
Using Sepsis-3 criteria for proven bacterial infections, procalcitonin showed 
the best performance in detecting sepsis. The AUC for procalcitonin was 0.68 
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(95% CI 0.65-0.71), which was comparable to the AUCs for the both 
composite biomarkers.  
Using the Swedish 2011 criteria for severe sepsis, the composite biomarkers 
performed better than any of the single biomarkers. The three-part biomarker 
had an AUC of 0.85 (95% CI 0.82-0.88) and the four-part biomarker had an 
AUC of 0.86 (95% CI 0.83-0.89). Thus, the additional value of procalcitonin 
to the three-part biomarker was small. One reason the composite biomarkers 
performed so well was probably due to the fact that lactate is part of the 
diagnostic criteria for severe sepsis. Another reason is that sepsis is a complex 
biochemical event where combined biomarkers may improve diagnostic 
accuracy compared to single biomarkers. 
For bacteremia, procalcitonin had the highest AUC 0.74 (95% CI 0.70-0.78), 
though not significantly higher than the NLCR, AUC 0.71 (p = 0.17; 95% CI 
0.67-0.75). The three-composite biomarker had an AUC of 0.75 (95% CI 0.71-
0.79). The four-composite biomarker had an AUC of 0.78 (95% CI 0.74-0.81), 
which was significantly better (all p < 0.001) than all markers but PCT (p = 
0.06). In several previous studies, PCT has shown the best performance for 
bacteremia, for example in the study by Gille-Johnson [71]. This was so even 
in this study, though procalcitonin was not significantly better than the NLCR. 
Advantages with the NLCR are that it reacts faster from disease onset than 
either procalcitonin or the CRP and is more sensitive and specific for acute 
bacterial infection than the leukocyte count. It is easily and rapidly analyzed at 
no or a very low extra cost from a normal blood count and is therefore suited 
to be part of the sepsis screening toolbox in the emergency departments.  
The combined three-biomarker using CRP, NLCR and lactate, improved 
diagnosis of the most critically ill sepsis patients. The combined biomarkers 
were designed using discriminant analysis, a method that could easily be 
applied in the laboratory output systems and evaluated in further studies. 
Combinations of biomarkers, vital signs and clinical data could be used to even 
further improve sensitivity and specificity of a screening tool for early sepsis 
diagnostics. 
4.5 Paper V. Symptoms of sepsis 
Upon reviewing almost 3,000 episodes of suspected sepsis in the 
epidemiological study, it became obvious that there were six symptoms 
recurring over and over, regardless of the focus of the infection or the causing 
pathogen. These symptoms were characterized by sudden onset, in minutes or 
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a few hours, and so pronounced that they prompted the patients to seek medical 
care. Figure 7.These symptoms were: Sudden onset of 
 fever and/or rigors 
 dyspnea 
 confusion or lowered level of conscience  
 vomiting and/or diarrhea 
 severe pain, related or unrelated to the focus of the infection. 
 pronounced muscle weakness. 
Figure 7. Systemic symptoms seen in patients with sepsis. These symptoms vary between 
patients, giving rise to many different clinical pictures. Thus, “Sepsis has many faces”. 
The silhouettes are those of historical persons who have made great contributions to our 
abilities to identify, prevent and treat sepsis. These are: Ignaz Semmelweis, Alexander 
Fleming, Louis Pasteur, Joseph Lister, Robert Koch and Edward Jennings. Illustrations 
by Lars Duvander. 
In a joint venture within Region Västra Götaland, these symptoms were 
evaluated in a study performed at Södra Älvsborg Hospital in Borås. As in the 
epidemiological study, all adult patients who, during the month of March 2012, 
had received intravenous antibiotic treatment for suspected sepsis were 
retrospectively examined for these symptoms. 
Sepsis has many faces
Sudden rigors/fever 
Sudden dyspnea
Sudden severe pain Sudden muscle weakness
Sudden change of mental status
Sudden nausea
and/or diarrhoea
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Out of 289 consecutive patients, 90 fulfilled any of the Swedish criteria for 
severe sepsis. Among those, presence of >3 of the suggested symptoms; fever, 
dyspnea, altered mental status, vomiting/diarrhea, severe pain or muscle 
weakness, significantly correlated to presence or development of severe sepsis. 
This was true even when the results were corrected for altered mental status as 
a confounder, since altered mental status is also a criterion for severe sepsis. 
In patients with >3 of the symptoms there was also a tendency towards higher 
frequency of positive blood cultures and to higher in-hospital death. Figure 8. 
Figure 8. Frequency of severe sepsis, bacteremia, and in-hospital death within sub-
groups based on number of systemic symptoms 
Of individual symptoms, acute change of mental status and dyspnea, 
significantly correlated to severe sepsis. Figure 9. 
 
 
 
 
 
 
 
Figure 9. Odds ratios for severe sepsis for individual symptoms with 95% CI, adjusted for 
age, gender and comorbidities as confounders. Weakness=muscle weakness. 
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Though some symptoms of sepsis have been documented in previous studies, 
it was not until 2017 that there was a systematic study on the symptoms of 
sepsis, published by Wallgren [132]. The study was a mixed methods analysis 
of presentations of septic patients as documented in Emergency Medical 
Services (EMS) records in the Stockholm area, Sweden. The symptoms most 
commonly found were: fever, pain, acute alteration of mental status, weakness 
of the legs, breathing difficulties, loss of energy, and gastrointestinal 
symptoms. These are almost identical with the symptoms we found by 
observation in patient records and that were used in our study, thus verifying 
our basic presumptions. 
Do symptoms of sepsis relate to disease severity? One model for understanding 
the symptoms of sepsis is that the more serious the disease, the more 
pronounced the symptoms of the dysregulated immune response than of the 
focal infection. In the example of the patient with erysipelas (p. 11), the patient 
only complained of upper abdominal pain, not of pain in the leg though that 
was the focus of the infection. One study supporting this theory is a French 
study by Denis [133], who found that respiratory symptoms were common in 
patients with E. coli pyelonephritis, and significantly more common in those 
having E. coli bacteremia than in those with no bacteremia. 
Interestingly, in Borås Hospital, the initially suspected focus of infection has 
been registered for more than a decade in all patients receiving antibiotic 
treatment. The most commonly found bacteria in patients with clinically 
suspected community-acquired pneumonia is - E. coli! (A Lundquist, personal 
communication). 
As illustrated by the example of James Hudson Taylor, symptoms alone could 
in 1852 be used by a doctor to both diagnose and give a prognosis of sepsis. 
Maybe it is time to recapture this forgotten knowledge, to use it in medical 
education and to integrate it into algorithms designed to identify patients with 
possible sepsis, not least in a pre-hospital setting. 
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5 CONCLUSIONS 
Using the Swedish 2011 criteria, we found an incidence of severe sepsis, of 
276/100,000 in this population based study of patients with suspected sepsis,  
The incidence of Sepsis-3 was three times that of severe sepsis, 878/100,000, 
mainly due to a high rate of patients having respiratory dysfunction. 
The incidence of bacteremia was high, 203/100,000/year, higher than in most 
previous studies, despite being in community onset bacteremia only. The rate 
of blood cultures before start of antibiotic treatment was >99%. 
Risk factors for severe sepsis were age >75 years, cardiovascular disease, 
diabetes mellitus, and “other” co-morbidities. 
The overall 28-day CFR in the whole study population was 8.6%. Among 429 
patients with severe sepsis the 28-day CFR was 25% and in those with non-
severe sepsis it was 4%. Among 1,362 patients with Sepsis-3, the 28-day CFR 
was 12%, and in those with non-Sepsis-3 it was 2%. 
The 28-day CFR in patients with bacteremia was 13%, as in similar 
Scandinavian studies. However, the 28-day CFR was linked to severe sepsis 
or not, and was not higher than in either patients with severe sepsis or non-
severe sepsis but without bacteremia. 
Independent risk factors for 28-day case fatality in those with severe sepsis 
were; age ≥75 years, cerebral dysfunction, renal dysfunction, respiratory 
dysfunction, and temperature on arrival. The lower the temperature on arrival, 
the higher the risk.  
Adding the results of commercial multiplex PCR on whole blood to the results 
of blood culture increased the detection rate of clinically relevant etiological 
findings. However, the multiplex PCR did on the one hand not identify all 
bacteria found by blood culture and on the other hand yielded findings that did 
not correlate to either the clinical or the bacteriological diagnosis. 
Respiratory viral infections were more common in patients with suspected 
sepsis and a respiratory focus or unknown focus than clinicians were aware of. 
The most often found virus in patients with respiratory tract infections was 
influenza A, followed by metapneumovirus and respiratory syncytial virus. 
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For detecting severe sepsis, a combination of the commonly used biomarkers, 
CRP, NLCR and lactate, had the best performance. For identifying verified 
bacterial infections of any severity, the NLCR and procalcitonin exhibited 
equal performance. 
Sudden onset of; fever and or rigors, dyspnea, altered mental status, 
vomiting/diarrhea, severe pain or severe muscle weakness, are symptoms that 
can be used to identify patients with suspected sepsis, especially in a pre-
hospital setting.  
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6 FUTURE PERSPECTIVES 
Sepsis constitutes a large proportion of hospitalized patients with high costs 
and high case fatality rates. Sepsis incidence, characteristics and outcomes 
should therefore be monitored continuously or at regular intervals in Swedish 
hospitals. The online-based national Swedish “infection tool”, with mandatory 
registration of all intravenous antibiotic prescriptions, will facilitate 
identification of patients to be evaluated and make future studies easier to 
conduct. Thus, patients with hospital-acquired sepsis can also more easily be 
found. Electronic protocols linked to a hospital database could greatly simplify 
data collection and evaluation.  
New techniques for rapid identification of patients with sepsis or patients with 
infection at risk of developing organ dysfunction are under development. In a 
near future we may be using molecular diagnostics and other biomarkers than 
today, like heparin binding protein, or micro-RNAs [134], combinations of 
biomarkers, or combinations of biomarkers and other markers of infection. 
Using microchip techniques, results may be available within few minutes and 
presented to the clinician already in the emergency department. 
Maybe in a near future, immunotyping, as described by Kaczorowski [135], 
will allow for identification and continuous follow-up of patients at risk of both 
acquiring severe infections and for having poor outcomes? 
6.1 Personal reflections 
I view sepsis very much as a disease of age, reflecting the ageing immune 
system, where varying parts of our native defense systems are deteriorating at 
different pace in different individuals, causing imbalances within the system. 
One result is the increased incidence of sepsis in the elderly. The changes in 
symptoms, vital signs and biochemistry in the individual person may to some 
extent depend on this imbalance. They may also depend on pre-existing co-
morbidities or simply aged organ systems with diminished abilities to 
withstand the assault of an infection. Sepsis in the elderly adds dysregulation 
of the immune system to an already impaired immune system as well as to 
several of our essential organ systems, resulting in increased in-hospital case 
fatality rates, long term disabilities and increased long term case fatality rates. 
Early identification and early effective treatment can halt the infection and 
slow down the immune reaction before organ dysfunction has become too 
pronounced, thereby reducing the harmful effects of sepsis. This is probably in 
analogy with acute myocardial infarction, which affects the ageing heart that 
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is predisposed to myocardial infarction, but where early intervention saves life 
and reduces muscle dysfunction, thereby reducing morbidity and even long 
term case fatality rates.  
There is yet no biomarker or vital sign for a priori assessment of an ageing and 
dysfunctioning immune system, but maybe the lack of fever (>38oC) in sepsis 
is a proxy for an immune system that is incapable of mobilizing enough 
defense to combat the infection?  
In contrast, in younger adults, below the age of 50, without severe co-
morbidities, having a healthy immune system, sepsis is a rare event. They may 
spend long time in hospital and may have debilitating sequelae, but they rarely 
die from sepsis.  
For early identification of sepsis, there is no single symptom, biomarker, or 
vital sign that identifies all persons with sepsis. However, extreme values in 
known markers of sepsis should alert every doctor to include sepsis as a 
possible or contributing cause of these changes. Of symptoms, the more of 
fever, dyspnea, altered mental status, severe pain, vomiting/diarrhea, or muscle 
weakness, the more likely sepsis is. Of vital signs, though not specific for 
sepsis, low oxygen saturation, low systolic blood pressure, acutely altered 
mental status or level of consciousness, are indicators of organ dysfunction that 
demand urgent evaluation also for possible sepsis. Increased respiratory rate, 
>24/min or definitely >30/min, is probably the fastest and most significant alert 
system for possible sepsis. Low temperature, in the presence of organ 
dysfunction due to infection, is another sign of severe disease with high risk of 
case fatality. Of biomarkers, extreme levels of leukocytes, neutrophils, 
lymphocytes (low), thrombocytes (low), CRP, procalcitonin, or lactate should 
also raise the suspicion of sepsis. The more of these markers of sepsis that are 
present at different times during the course and the more extreme the values, 
the more likely the patient has sepsis or is about to develop sepsis.  
Any doctor familiar with these markers of sepsis, their different presentation 
in different individuals and their variation over time, will by and by learn to 
discern the sometimes diffuse picture of sepsis, even though not all the pieces 
of the puzzle are at hand and not at every moment of the disease. 
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 APPENDIX 
The natural history of a case of severe sepsis in 1852: 
At the age of 17, John Hudson Taylor (1832-1905) was called by God to 
become a missionary to inland China, in those days a country closed to 
foreigners. One way to be accepted in China was through becoming a doctor. 
In 1852 he started studying medicine at the Royal College of Surgeons in 
London, where he was staying with an uncle.  
This recollection of the natural history of the course of a septic infection is 
found in the diary of John Hudson Taylor, cited in the “Biography of John 
Hudson Taylor” by Dr. and Mrs. Howard Taylor. China Inland Mission 1965. 
Pages 43-45: Published with permission of the OMF, Overseas Missionary 
Fellowship www.omf.org. OMF is since 1964 the successor of CIM, China 
Inland Mission, founded by James Hudson Taylor and his wife in 1865. 
”Very soon after this, possibly the same evening, while sewing together some 
sheets of paper on which to take notes of lecture, I accidentally pricked the 
first finger of my right hand, and in a few moments forgot all about it. 
The next day at the hospital I continued dissecting as before. The body was 
that of a person who had died of fever, and was more than usually 
disagreeable and dangerous. I need scarcely say that those of us who were at 
work upon it dissected with special care, knowing that the slightest scratch 
might cost our lives. 
Before the morning was far advanced I began to feel weary, and while going 
through the surgical wards at noon was obliged to run out, being suddenly 
very sick – a most unusual circumstance with me, as I took but little food and 
nothing that could disagree with me. 
After feeling faint for some time, a draught of cold water revived me and I 
was able to rejoin the students. I became more and more unwell, however, 
and during the afternoon lecture on surgery I found it impossible to hold the 
pencil and continue taking notes. By the time my next lecture was over, my 
whole arm and right side were full of pain, and I was both looking and 
feeling very ill. 
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Finding that I could not resume work, I went into the dissecting-room to bind 
up the portion I was engaged upon and put away my apparatus, and said to 
the demonstrator, who was a skillful surgeon: 
‘I cannot think what has come over me’, describing the symptoms. 
‘Why’, said he, ‘what has happened is clear enough. You must have cut 
yourself in dissecting, and this is a case of malignant fever.’ 
All at once it occurred to me that I had pricked my finger the night before, 
and I asked him if it were possible that a prick from a needle at that time 
could have been still unclosed. His opinion was that this was probably the 
cause of the trouble, and he advised me to get a hansom, drive home as fast 
as I could and arrange my affairs forthwith: 
‘For,’ said he, ‘you are a dead man’. 
My first thought was one of sorrow that I could not go to China; but very 
soon came the feeling, ‘Unless I am greatly mistaken, I have work to do in 
China and shall not die’. I was glad, however, to take the opportunity of 
speaking to my medical friend, who was a confirmed sceptic, of the joy that 
the prospect of soon being with my Master gave me, telling him at the same 
time that I did not think I should die, as unless I was much mistaken I had 
work to do in China, and if so, however severe the struggle, I must be 
brought through. 
‘That is all well’, he answered, ‘but get a hansom and drive home as fast as 
you can. You have no time to lose, for you will soon be incapable of winding 
up your affairs’. 
I smiled a little at the idea of riding home in a hansom, for by this time my 
means were too exhausted to allow for such a proceeding, and I set out to 
walk the distance if possible. Before long, however, my strength gave way 
and I felt it was no use to attempt to reach home by walking. 
On going into the house I got some hot water from the servant, and charging 
her very earnestly – literally as a dying man – to accept life as the gift of God 
through Jesus Christ, I bathed my hand and lanced the finger, hoping to let 
out some of the poisoned blood. The pain was very severe. I fainted away, 
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and was so long unconscious that when I came to myself, I found I had been 
carried to bed. 
My uncle sent for his own medical man, an assistant surgeon at the 
Westminster Hospital. When the surgeon came and learned all the particulars 
he said, 
‘Well, if you have been living moderately you may pull through, but if you 
have been going in for beer and that sort of thing there is no manner of 
chance for you’.  
I thought that if sober living was to do anything, few could have a better 
chance. 
‘But now, he said, you must keep up your strength, for it will be a pretty hard 
struggle’. And he ordered me a bottle of port wine every day and as many 
chops as I could consume. I smiled inwardly, having no means for the 
purchase of such luxuries. This difficulty, however, was met by my kind 
uncle, who sent me at once all that I needed…… 
Days and nights of suffering passed slowly by; but at length, after several 
weeks, I was sufficiently restored to leave my room; and then I learned that 
two men, though not from the London Hospital, who had had dissection 
wounds at the same time as myself, had both succumbed, while I was spared 
in answer to prayer to work for God in China. 
After some months of recovery James Hudson Taylor was able to resume his 
studies. He did survive and became a missionary to inland China, where he 
died at the age of 73 years. 
